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Antimicrobial resistance is one of the serious global challenges in the current 
century. The fact that resistance genes transfer between bacteria, coupled with the fact 
that the world is connected through complex dynamics. Studying microbial behavior 
and understanding the different factors coffering microbial resistance to a broad 
spectrum of the available drug classes, parallel with a comprehensive analysis of the 
natural microbial products as the primary source of the novel antibiotics, might shed 
some light on solutions for this problem. 
Microbial environments harbor a wide range of secondary metabolites (SM) with 
different functional groups. SMs are not directly involved in vital microbial processes 
such as reproduction, growth, and development. However, these organic compounds, 
which exist in many different chemical structures, carry out a broad range of functions. 
Some bioactive SMs are widely used in drug development of various therapeutic classes 
such as antibacterial, anticancer, immunosuppressant, diabetic, and cholesterol-
lowering agents. These bioactive compounds’ metabolic pathways are encoded by co-
localized genes collectively called Biosynthetic Gene Clusters (BGCs). The majority of 
the discovered bioactive natural products are from microbial strains that are 
cultivatable. However, the advancement in sequencing techniques, bioinformatics, and 
metagenomics opened unlimited opportunities to reach and study the uncultivatable 
microbial communities, which represent the more significant fraction of the 
underexplored microbial ecology. 
In this study, selected samples of seven selected metatranscriptomic/metagenomic 
datasets were subjected to assembly, taxonomic assignment to the reads, and assembled 
contigs. The aim of this study is two-fold. Firstly, the assembled contigs were then 
investigated by two primary distinct computational methods, namely antibiotics and 
Secondary Metabolite Analysis Shell (antiSMASH) and deep-learning (deepBGC) 
methods. A comparative study was performed to determine the biosynthetic gene 
clusters (BGCs) present in each of the included samples and compare their taxonomic 
differences. Secondly, the assembled contigs were also analyzed to determine the 
antimicrobial resistance (AMR) genes present in each sample by using the Resistance 
Gene Identifier (RGI) algorithm, which is a part of the Comprehensive Antibiotic 
Resistance Database (CARD). A total of 65 samples from the seven selected 
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metagenomic and metatranscriptomic datasets were investigated by antiSMASH, 
deepBGC pipelines, and CARD in the present study. The different classes of detected 
BGCs and their corresponding microbial taxa and the antimicrobial resistance gene 
families and their corresponding resistance mechanisms against specific drug classes 
were reported. 
In the current study, we reported that the datasets with a large extent of variability (i.e. 
sex, age and illness state) due to the nature of their environments, such as host 
microbiome samples of patients in two ecosystems (COVID-19 & Atopic Dermatitis), 
gave the most variable number of BGC classes detected by antiSMASH, where 19 
different classes detected in skin microbiome of AD patients and 16 different classes 
detected in gut microbiome of COVID-19 patients. On the other hand and due to the 
selection pressure on the microbial ecosystems by the wide use of antibiotics, gut 
microbiome of COVID-19 patients’ and water sewage samples had more than 70% of 
the detected AMR gene families where gut microbiome of COVID-19 patients’ sample 
alone reported to had more than 50% of AMR genes detected by CARD. 
In conclusion, ecological characteristics and microbial diversity in terms of composition 
and relative abundance dramatically affect the dynamics of secondary metabolites’ 
production and transferring antimicrobial resistance genes between bacteria. Microbial 
strains with higher biosynthetic and antimicrobial resistance potentials were enriched 
in environments with a rich microbial diversity such as host microbiome (i.e., COVID-
19 patients), with patterns of abundance of biosynthetic gene clusters and AMR genes 
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Chapter 1: Literature Review & Study Objectives 
Introduction 
Global health challenges associated with antibiotic and chemotherapeutic 
resistances:  
On 5 February 2018, the WHO summarized the global challenge associated with 
antibiotic resistance as follows, “antibiotic resistance is one of the major threats to 
global health, food security, and development, and its effect could extend to include 
everyone regardless of their ages or their country (Antibiotic resistance, 2020). A 
growing number of infections – such as pneumonia, tuberculosis, gonorrhoea, and 
salmonellosis – are becoming harder to treat as the antibiotics used to treat them become 
less effective”. Moreover, these infections could lead to longer hospital stays, higher 
medical costs, and increased mortality (Antibiotic resistance, 2020). Every year, around 
2 million people in the US are infected by a bacterial strain that is resistant to all existing 
antibiotics (Martens & Demain, 2017). Furthermore, the resistance of chemotherapeutic 
anticancer drugs following therapy is a rising global health challenge (Holohan et al., 
2013). Therefore, there is an unmet need and a great pressure on scientists and the health 
communities for discovering new alternative drugs to the current overused ones. Hence, 
exploring Natural Products (NPs) could provide a rich source of potentially effective 
drugs (Hernando-Amado et al., 2019). Deeper analysis of bacterial behavior in their 
respective communities is very crucial, recent studies shed the light on the key role of 
environments as a corner stone in not only the transmission of resistance genes between 
different bacterial species but also has an important role in emergence of pathogens with 
elevated level of resistance (Bengtsson-Palme et al., 2018).  
Natural Products and their pharmaceutical importance 
In nature, a wide range of secondary metabolites (SM) with different functional 
groups is produced by plants and microbes such as bacteria and fungi (Davies & Ryan, 
2012). Unlike primary metabolites, SMs are not directly involved in vital processes (i.e. 
reproduction, growth & development) of the organism. However, these organic 
compounds which exist in many different chemical structures carry out a broad range 
of functions. In the mid-20th century, after the great discovery that some microbial 
natural products have an antimicrobial activity, an endless intensive research work has 
started and a wide range of microbial strains has been randomly screened for the 
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presence of natural byproducts with potential therapeutic activities (Davies & Ryan, 
2012). These efforts yielded hundreds of thousands of SMs to be extracted and tested 
as antimicrobial agents (Davies & Ryan, 2012). Moreover, scientists harnessed the 
power of SMs to be utilized as antimicrobials, anticancer, immunosuppressant, and 
cholesterol-lowering agents and many others (Ruiz et al., 2010).   
These natural products (NP) play a crucial role in drug discovery and 
development. According to David J. Newman in 2016, about 70% of anti-infective 
medicines originated from natural products (Newman & Cragg, 2016). Over 33 years, 
from 1981 to 2014, 32% of small molecule medicines approved by the FDA were 
natural products either unmodified (6%) or NP derivatives (26%) (Newman & Cragg, 
2020). These drugs include different therapeutic classes such as antimicrobial, 
anticancer, diabetic, immunosuppressant, and cholesterol-lowering agents (Newman & 
Cragg, 2020). 
Natural Products are encoded by Biosynthetic Gene Clusters (BGCs) 
Previous reports investigating the characteristics of bioactive secondary 
metabolites revealed that the metabolic pathways of SMs are encoded by co-localized 
genes collectively called Biosynthetic Gene Clusters (BGCs) (Martin, 1992). Genes 
encoding for the biosynthetic pathway enzymes as well as their respective regulatory 
genes are contained in the BGC region (Keller et al., 2005). Notably, this fact paves the 
way for in silico mining of genomes and metagenomes for secondary metabolites 
through BGC neighborhood identification (Medema & Fischbach, 2015). So far, 
biosynthetic systems could be grouped into two major classes, Non-ribosomal peptide 
synthases (NRPS) and Polyketide synthases (PKS) (Weber & Kim, 2016). On the other 
hand, PKS and NRPS are responsible for synthesizing a wide and varied spectrum of 
bioactive natural products with much biomedical research and therapeutic applications 
such as antimicrobial, antifungal, and immunomodulatory agents, therefore PKS and 





Tools for BGC mining and NP Discovery 
NP mining: past, present and future 
Prior to the omics era and the advancement of DNA sequencing technologies, 
exploring microorganisms for natural products was mainly conducted in the laboratory 
using culture-dependent techniques (Katz & Baltz, 2016). The classical way of natural 
products discovery typically consists of four main steps, starting with isolating the 
microbial samples, cultures enrichment, extracting candidate products and finally 
screening and screening their activities. One major drawback to this traditional method 
is the difficulty to culture microorganisms in the lab, besides that not all microbes can 
be grown in stable enrichments. To date, only a small fraction of microbial species could 
be cultured in the laboratory (Stewart, 2012). Growing microorganisms in the laboratory 
under diverse conditions was frequently used to produce and identify secondary 
metabolites without being able to specify their biosynthetic pathways at the genetic 
levels (Luo et al., 2014). Secondary metabolites functions and activities are usually 
characterized and validated through different biochemical assays. Recently, high 
throughput biochemical assays enabled the discovery of a wide range of unprecedented 
secondary metabolites with potential antimicrobial activities. One notable example, in 
a study of sugar fermentation in a Vibrio Cholerae culture, 49 out of 39,000 crude 
extracts screened were able to block fermentation pathways and 3 products with novel 
antimicrobial activities were identified representing a new class of broad-spectrum 
antibiotics (Chen et al., 2019). One major limitation linked to solely using biochemical 
assays to detect and characterize SMs is the fact that some SMs are formed at 
undetectable levels. Therefore, it will be more feasible to integrate biochemical assays 
with other approaches to capture a broader range of SMs produced in nature (Luo et al., 
2014). 
Omics Approaches in NP Discovery 
Many pharmaceutical drugs which are approved for use by health authorities all 
over the world, have been discovered as a result of the traditional approaches of NP 
discovery. However, the rate of NP discovery has declined dramatically due to the 
difficulties of identifying novel compounds and the recurrent discovery of known 
compounds (Li & Vederas, 2009). Extraordinary opportunities for NP discovery 
through identification and characterization of biosynthetic gene clusters (BGCs) have 
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been created by genome sequencing technology (Jensen, 2016). While the early 
approaches in genetics were based on progressing from phenotype to genotype, the 
introduction of the next-generation sequencing techniques along with whole-genome 
sequencing approaches, creates databases waiting to be mined for novel BGCs 
discovery, characterization and synthesis through reverse genetic engineering 
approaches, from genotype to phenotype. The massive progress of genomic resources, 
especially microbial whole-genome sequencing, not only for the cultured organisms but 
also for the uncultured ones, has led to a notable paradigm shift in the uses of 
computational approaches in the discovery of bioactive natural products (Hannigan et 
al., 2019). 
Genome mining is considered a highly time and cost effective approach in NP 
discovery because it allows researchers to examine huge genomic datasets whether it 
harbor biosynthetic gene clusters of interest or not, before undertaking any expensive 
and laborious biochemical steps to produce and extract the NP from microbial host. 
Omics approach makes it possible to identify a very large number of BGCs in different 
genomes and explore the chosen BGCs for experimental and systematic 
characterization (Chen et al., 2019). 
In silico Tools for Biosynthetic Gene Clusters Identification 
The rapid advances in the DNA sequencing techniques inspired the development 
of in silico tools and pipelines to mine microbial genomes and metagenomes for the 
presence of biosynthetic gene clusters (Table 1. showing a summary of the tools widely 
used to predict the biosynthetic gene clusters). The vast majority of them utilize Basic 
Local Alignment Search Tool (BLAST) or profile hidden Markov models (HMMs) 
searching tools as a base to identify the genetic signatures accountable for NP 
biosynthesis (Ren et al., 2020). These tools include NAPDOS, antiSMASH, 
NP.searcher and ClustScan, which are known for their high accuracy yet low levels of 
novelty. Moreover, genome mining can be leveraged by the presence of databases for 
the known BGCs such as antiSMASH (antibiotics & Secondary Metabolite Analysis 
Shell) and MIBiG (Minimum Information about a Biosynthetic Gene Cluster) (Blin et 
al., 2017) and (Starcevic et al., 2008).  In 2019, Hannigan, Geoffrey D et al. introduced 
DeepBGC as a novel approach integrating deep machine learning with natural language 
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processing for a better outcome in terms of precision and accuracy in BGCs 
identification in microbial genomes (Hannigan et al., 2019).  
Table 1. List of the widely used tools and pipelines for prediction of BGCs, data was modified from Ren 
H et al., 2020 
Tools Target(s) Predicted BGC class Reference 
AntiSMASH Bacteria & fungi Wide range  Blin et al., 2013 
NP.searcher Bacteria NRPS, PKS & NRPS/PKS Li et al., 2009 
ClustScan Bacteria NRPS & PKS Starcevic et al., 2008 
ClusterFinder Bacteria Wide range Cimermancic et al.,2014 
NaPDoS Metagenomics NRPS & PKS Ziemert et al., 2012 
eSNaPD Bacteria Wide range Reddy et al., 2014 
EvoMining Bacteria Wide range Selem-Mojica et al., 2019 
SMURF Fungi 
NRPS, PKS, NRPS/PKS & 
DMATS 
Khaldi et al., 2010 
PantiSMASH Plant Wide range Kautsar et al., 2017 
BAGEL Bacteria Bacteriocin & RIPP Van Heel et al., 2013 
 
Genomics and High-throughput Sequencing Technologies 
Applying high throughput sequencing techniques in the study of microbial 
communities was the biggest reason behind creation of metagenomics research field; as 
it enables, for the first time, the study of different genomic sequences of co-existing 
microorganisms in a certain community (Ghurye et al., 2016). Sequencing technologies 
have been dramatically advanced during the past four decades. Sanger sequencing 
considered the first revolution discovery in modern genetic analysis because it allow 
complete genome sequencing for the first time. Later, genome sequencing became faster 
and much cheaper when the next-generation sequencing (NGS) technologies had 
appeared, regardless its advancement, NGS technologies have several drawbacks, most 
remarkably the problem of short reads (i.e. it produces up to several hundreds of base 
pairs). Recently, such pitfall has been solved by applying the third-generation 
sequencing technology which can produce long reads, up to several tens of kb, and 
genomic assemblies of extraordinary quality (van Dijk et al., 2018).  
Long-read sequencing approaches had been enhanced over the recent years. 
Therefore, enabling the study of different genomic sequences and transcriptomes at an 
extraordinary resolution, therefore, metagenomics analysis could go deeper to the 
species level (Pootakham et al., 2017); (Kuleshov et al., 2016). In the near future, long-
read sequencing has a great possibility to become a standard method in medical 
diagnosis. A recent SMRT study of a patient’s genomic sequence showing undetected 
SV despite the aggressive genetic testing by other approaches (Merker et al., 2018).  
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Moreover, ambiguous regions in genomes are no longer big issues and can now be 
resolved, and more details will be elaborated from transcriptomes. Thus long-read 
methods are leading a series of revolutionary new discoveries in genomics research. 
Many long-read platforms are now available such as; PacBio, ONT and Illumina/10X 
Genomics SLR, table 2 summarize some of their strengths and highlighting their 




ONT  Ultra long reads; a one Mb reads 
can be obtained 
 Cost effective (e.g. MinION) 
 Epigenetic modifications are 
directly detected 
 Very fast library preparation 
 Portable (e.g. SmidgION)  
 High error rate 
 Library preparation needs big 
amount of starting material 
 Software versions subjected to 
numerous changes 
PacBio  High accuracy with CCS greater 
than 99% at 20 passes. 
 Epigenetic modifications are 
directly detected 
 Overcome repeats problem 
 Expensive with high cost per Gb 
 Library preparation needs big 
amount of starting material 
 High error rate 
 Only Sequel sequencer is 
available. 





 High accuracy and low error rate 
 Low cost per Gb 
 No need for special equipment 
 Library preparation needs small 
amount of starting material 
 
 No real long reads 
 Library preparation needs PCR 
amplification 
 Epigenetic modifications 
couldn’t detected directly 
 Limited capacity (i.e. 384 wells) 
 
 
The importance of searching for BGCs in metagenomes 
Metagenomics is the study of genetic material of samples, recovered directly 
from the environment. Unlike the cultivated-based methods such as microbial genome 
sequencing, early environmental genomics rely upon sequencing of cloned specific 
genes (i.e. 16S rRNA gene) to generate a profile showing the microbial biodiversity in 
nature. As a result of applying metagenomics approaches, a whole world of endless 
different species has been discovered (Hugenholtz et al., 1998). 
The vast majority of the discovered bioactive NP are products of microbial 
strains that can be cultivated in the laboratory. However, metagenomics studies open 
Table 2. Strengths and weaknesses of some available long-read platforms, data was modified from van 
Dijk EL et al., 2018 
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unlimited possibilities to reach and study the uncultivated microbial communities which 
represent the bigger fraction of the underexplored microbial ecology. Furthermore, 
novel biosynthetic pathways are being discovered at higher rates compared to the old 
techniques of molecular biology.  In addition, metagenomics would also serve as a great 
tool to study biocatalysts from the previously overlooked cultivated microbial strains 
which reflects a very good probability to discover novel compounds (Wilson & Piel, 
2013). 
AntiSMASH platform to detect BGCs 
AntiSMASH is an inclusive in silico pipeline widely used to explore bacterial 
and fungal genome sequences to identify BGCs regions of a broad range of secondary 
metabolites (Medema & Fischbach, 2015) such as polyketides, terpenes, non-ribosomal 
peptides, bacteriocins, lantibiotics, siderophores, indolocarbazoles, aminocoumarins, 
aminoglycosides, beta-lactams, melanins, butyrolactones and others. Although, 
antiSMASH relies on signature gene profile HMMs for BGCs identification, they apply 
a greedy algorithmic method to extend the explored regions by 5, 10, or 20 kb on both 
sides hence closely localized clusters can be merged into what’s called superclusters.   
In the latest version (v.5.0) of antiSMASH pipeline (Blin et al., 2019), 
superclusters is relabeled as regions, and each region contains several mutually 
exclusive candidate BGCs for improved interpretation of hybrid clusters. Moreover, 
there are others additional options provided by antiSMASH such as, domain analysis 
and annotation of NRPS/PKS, core chemical structure prediction of non-ribosomal 
peptides and polyketides, comparative analysis of gene clusters by ClusterBlast, and 
protein family analysis of secondary metabolites (smCOG). The output can easily be 
visualized through an interactive XHTML page with a user-friendly interface (Ren et 
al., 2020). It is worth mentioning that there is another derivative of antiSMASH used 
for plant genome mining called plantiSMASH and it has ability to identify biosynthetic 
pathways between and within gene clusters by co-expression analysis, and also it can 
be used to study the evolutionary conservation of each gene cluster through comparative 
genomic analysis (Kautsar et al., 2017). 
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Deep learning method to detect BGCs 
While they considered the gold standard for genome mining, current available 
pipelines, such as ClusterFinder and antiSMASH, are based mainly on signature gene 
profile HMMs for BGCs identification but they miss the ability to remember the effects 
of position dependencies between distant units or order information (Yoon, 2009); 
(Eddy, 2004). This leads to the fact that such tools, HMM-based, could not grasp higher 
order information among units (Yoon, 2009; Eddy, 2004), as a result they had a limited 
ability to detect BGCs.  
To address this algorithmic limitation, Hannigan, Geoffrey D et al. implement a 
deep learning approach, DeepBGC, as a novel pipeline integrating deep machine 
learning with natural language processing (NLP) for a better outcome in terms of 
precision and accuracy in BGCs identification in microbial genomes (Hannigan et al., 
2019). To overcome limitation of HMM-based tools, DeepBGC applying both 
Recurrent Neural Networks (RNNs) and vector representations of protein family (Pfam) 
domains (Finn et al., 2016) which together have the ability of inherently sensing short 
and long term effects of position dependency between neighboring and distant entities 
(Sepp Hochreiter et al., 2007).  
DeepBGC applies a Bidirectional Long Short-Term Memory (BiLSTM) RNN 
besides a word embedding skip-gram neural network, word2veclike, called pfam2vec 
(S. Hochreiter & Schmidhuber, 1997). Implementation of DeepBGC produce a higher 
performance compared to the leading algorithms in terms of the accuracy of BGC 
detection from different genome sequences and the ability of identification of novel 
classes of BGCs. Additionally, DeepBGC can classify the identified BGCs based on 
their corresponding product classes and the product molecular activity by using a 
generic random forest classifiers. 
DeepBGC considered a new powerful tool which when applied to bacterial 
reference genomes could identify biosynthetic gene clusters coding for bioactive 
molecules with putative antimicrobial activity that never identified by the other existing 
pipelines. Moreover, the power of this tool might be used in metagenomic analyses in 
addition to microbial reference genome, this might leads to a new era of improved BGC 
detection and unlimited possibilities to identify novel BGCs (Hannigan et al., 2019). 
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Study Objectives  
In this study, selected samples pertaining to seven selected metatranscriptomic 
/ metagenomic projects were subjected to assembly, taxonomic assignment to the reads 
and assembled contigs. Aim of this study is two-fold. Firstly, the assembled contigs 
were then investigated by two major distinct computational methods, namely antibiotics 
and Secondary Metabolite Analysis Shell (antiSMASH) and deep-learning (deepBGC) 
methods. A comparative study was performed to determine the biosynthetic gene 
clusters (BGCs) present in each of the included samples, as well as comparing their 
taxonomic differences. Secondly, the assembled contigs were also analyzed to 
determine the antimicrobial resistance (AMR) genes present in each samples by using 
Resistance Gene Identifier (RGI) algorithm which is a part of the Comprehensive 
















Chapter 2: Materials & Methods 
Samples and Assembly 
Whole metagenome samples were obtained from NCBI Sequence Read Archive 
(SRA) using prefetch then the downloaded SRA files were converted into paired-ended 
FASTQ using fastq-dump. FASTQ files were processed for quality control to remove 
adaptor sequences, trim low-quality ends, and remove short reads using fastp (Chen et 
al. 2018). Filtered sequences were sub-sampled to one million reads per sample (run) 
using Seqtk https://github.com/lh3/seqtk, Figure 1 showing the distribution of filtered 
reads of all processed samples per each of the seven selected projects. Sequence reads 
were assembled using MEGAHIT (Li et al. 2015), Figure 2 showing the distribution of 
the assembled contigs per each project. Assembled contigs were taxonomically 
classified using Kraken 2 (Wood et al. 2019). Contigs were filtered for a minimum size 
of 1,000 nucleotides. 
 





Figure 2. Distribution of the assembled contigs per each project 
Taxonomic analysis, annotation and bioinformatic visualization 
Samples were taxonomically classified on the sequence reads using Kraken 2 
(Wood et al. 2019) with the default taxonomy database. The abundance of the different 
taxonomic levels (species, genus, family, etc.) was estimated using Bracken (Lu et al. 
2017). 
Using deepBGC tool for BGC mining 
 Biosynthetic gene clusters were predicted in the assembled contigs using 
deepBGC (Hannigan et al. 2019). Contigs classified as human were excluded from 
downstream steps (Figure 3). 
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Figure 3. The distribution of human abundance per each of the seven selected datasets. Excluded from 
downstream analysis 
Using antiSMASH tool for BGC mining 
The antibiotics and secondary metabolite analysis shell (antiSMASH) platform 
was utilized for detection of BGCs. antiSMASH bacterial version 5.0 was used with 
default parameters (Medema et al. 2011). 
Using CARD’s RGI algorithm for AMR genes detection 
The Resistance Gene Identifier (RGI) algorithm present in the Comprehensive 
Antibiotic Resistance Database (CARD) was exploited for determination of AMR 
genes, drug classes and their resistance mechanisms. The following RGI criterions for 
detection were applied, perfect, strict & loose, partial genes included, 95% identity 
nudge used and low quality coverage was used in the sequence quality option. (Alcock 
BP, Raphenya AR, Lau TTY, et al. 2020). Loose hits were excluded from downstream 
steps. 
Statistical Analyses  
Analytical and visualization analyses were performed using R: A language and 
environment for statistical computing. R Foundation for Statistical Computing, Vienna, 
Austria. URL https://www.R-project.org/.   
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Chapter 3: Results 
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Figure 4. The Study workflow for the major steps of the pipeline used to screen the selected metagenomic & 
metatranscriptomic projects included in the dataset for BGCs 
The study workflow is illustrated in Figure 4, and the details of samples used in
 this analysis are available in Table 3. In this study, a total number of 65 samples from 
seven selected projects were processed using both antiSMASH and deepBGC pipelines
 for BGCs mining and CARD’s RGI algorithm for AMR genes detection. The 
total number of reads used was 1,139,543,039 yielded 1,100,630,009 filtered reads
 and  generating  a  total  of  4,325,515  contigs  (Table  4).  The  contigs  (assembled 
metagenomes and metatranscriptomes) from the seven selected projects included in the
 dataset  were  investigated  by  two  major  distinct  computational  methods  (i.e. 
antiSMASH and deepBGC) in addition to CARD’s RGI algorithm for BGCs mining
 and AMR genes detection, respectively, the workflow is depicted in Figure 4, and a 
comparative  study  was  performed  to  determine  the  BGCs  present  in  each  of  the 
included  samples  along  with  detection  of  AMR  genes  with  their  corresponding 
mechanisms of action and drug classes which they were confer resistance to it. The 
assembly metrics are denoted in Table 4. 
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Table 3. The selected metagenomic and metatranscriptomic projects included in the dataset. The 
accession numbers of the seven selected datasets along with their corresponding abbreviated names and 
number of processed samples are denoted. A total number of 65 samples were processed using both 





Number of processed 
samples per dataset 
1 PRJDB6156 Osaka 9 
2 PRJNA340165 Tonga 5 
3 PRJNA472006 Nose 12 
4 PRJNA489681 Skin AD 10 
5 PRJNA624223 COVID-19 10 
6 PRJNA629394 Mangrove 10 
7 PRJEB13831 Sewage 9 























































# of Bases 
 
# of Reads 
 












Sequencing of Osaka 
Bay see water 
metatranscriptome 










2019-08-01 DRR099940 387.8 M 2,667,479 2,649,580 7,657 487 9,321 
DRR099941 1.1 G 7,509,742 7,382,595 45,800 559 59,858 
DRR099942 749.7 M 5,334,601 5,239,370 26,283 523 18,690 
DRR099943 864.7 M 5,921,570 5,813,994 36,796 454 139,294 
DRR099944 932.3 M 6,505,903 6,377,636 14,877 945 327,531 
DRR099945 382.6 M 2,612,159 2,581,855 15,734 737 21,593 
DRR099946 397.9 M 2,769,912 2,719,784 8,059 1,216 37,754 
DRR099947 673.22 M 4,642,688 4,581,593 18,774 378 8,907 
DRR099948 663.4 M 4,650,613 4,593,213 13,583 846 48,051 
       TOTAL (M) 6151.62       
Investigation of the 
metagenome of the 
Tonga trench 
sediment 
(at 9.2 km water depth 
and up to 2 m 
sediment depth) 





Metagenome Pacific Ocean 2016-08-25 SRR4069403 417.20 M 1,846,010 1,804,893 23,966 481 16,294 
SRR4069404 1.30 G 5,826,299 5,732,762 110,986 572 47,068 
SRR4069405 1.03 G 4,564,804 4,443,188 3,675 519 2,701 
SRR4069406 3.09 G 13,747,868 13,377,953 4,220 591 4,378 
SRR4069408 1.34 G 5,974,450 5,868,302 927 375 5,306 
       TOTAL (M) 7177.20      
Comparative 
metagenomic analysis 




and patients with 
atopic dermatitis 
(49 subjects, 33 AD 
patients and 16 
healthy controls) 
PRJNA489681 Multiple Metagenomes Metagenome Singapore 2018-09-06 SRR7802475 1.87 G 9,346,770 8,963,662 29,068 1,134 327,256 
SRR7802341 1.49 G 7,438,112 7,363,758 43,096 627 388,652 
SRR7802306 1.37 G 6,854,660 6,577,935 81,181 687 160,560 
SRR7802339 1.09 G 5,456,812 5,402,061 23,516 677 312,511 
SRR7802351 1.22 G 6,112,223 5,715,559 29,534 1,386 491,444 
SRR7802349 1.03 G 5,217,253 5,170,642 39,712 811 340,940 
SRR7802476 1.27 G 6,365,734 6,140,000 27,564 943 104,289 
SRR7802335 1.19 G 5,973,209 5,740,124 56,361 673 275,594 
SRR7802352 1.02 G 5,143,013 5,100,160 128,979 815 129,231 
SRR7802406 1.22 G 6,111,603 5,903,453 65,083 712 145,141 




along South China 








Metagenome South China 2020-04-29 SRR11734720 3.64 G 18,209,386 17,427,535 9,660 422 5,337 
SRR11734598 3.83 G 19,129,190 18,342,777 10,852 424 7,412 
SRR11734613 3.84 G 19,180,698 18,338,146 25,121 461 43,105 
SRR11734656 4.15 G 20,768,796 20,169,382 52,455 465 32,405 
SRR11734640 4.16 G 20,805,669 20,243,850 48,897 516 46,618 
SRR11734616 4.12 G 20,591,363 19,765,013 29,634 459 45,747 
SRR11734716 4.11 G 20,559,523 19,722,052 13,382 423 10,080 
SRR11734719 4.34 G 21,676,963 20,830,425 15,150 426 7,083 
SRR11734596 4.53 G 22,671,952 21,791,702 17,194 426 6,779 
SRR11734597 4.52 G 22,602,093 21,705,388 16,722 424 6,841 













in 15 COVID-19 
patients. 
 







Raw sequence reads Hong Kong 2020-04-10 SRR12328926 2.85 G 10,119,197 9,893,607 15,215 1,195 732,744 
SRR12328948 3.10 G 10,831,211 10,698,264 7,994 3,351 403,502 
SRR12328907 3.05 G 10,776,976 10,650,748 156,679 1,299 524,513 
SRR12328910 3.16 G 11,141,802 10,735,634 409,228 490 385,138 
SRR12328904 3.32 G 11,404,379 11,294,382 136,136 1,363 472,741 
SRR12328942 3.20 G 11,471,303 11,240,588 31,516 1,614 585,648 
SRR12328943 3.41 G 12,238,736 12,012,970 14,049 1,123 349,596 
SRR12328897 3.52 G 12,313,208 12,205,473 149,575 1,253 481,689 
SRR12328903 3.68 G 13,018,722 12,883,352 116,637 1,560 493,077 
SRR12328951 3.76 G 13,019,613 12,900,042 25,191 2,502 411,905 
       TOTAL (M) 33050      
Human skin 
metagenome and 16S 
(Epithelium of 
external nose)  





Raw sequence reads Denmark: 
Copenhagen 
2018-05-18 SRR9696273 8.2G 32,489,498 31,778,213 94,964 358 37,829 
SRR9696274 13.9G 55,186,070 53,638,515 43,565 337 16,576 
SRR9696275 9.1G 36,087,682 35,391,282 18,676 335 5,245 
SRR9696276 9.1G 35,935,443 35,178,043 30,113 335 16,689 
SRR9696277 8.8G 34,846,139 34,191,678 10,537 376 16,683 
SRR9696278 13.2G 52,223,806 50,934,770 44,869 337 4,667 
SRR9696279 9.6G 37,987,223 37,080,691 44,017 332 16,668 
SRR9696280 8.9G 35,189,492 34,402,185 3,275 329 3,917 
SRR9696281 12G 47,577,639 46,427,813 45,784 339 16,690 
SRR9696282 11.2G 44,434,656 43,402,757 42,952 338 16,668 
SRR9696283 7.8G 30,778,753 30,118,478 7,434 513 147,689 
SRR9696284 11.9G 47,163,030 46,080,142 23,316 331 16,668 
       TOTAL (M) 123700      
Global surveillance of 





PRJEB13831 Sewage Metagenomes Raw sequence reads Global project 2019-02-01 ERR1713410 8.2G 27,296,861 25,450,270 253,567 396 23,682 
ERR1713411 5.8G 19,360,109 18,017,557 233,836 394 32,340 
ERR1726031 1.2G 3,919,046 3,659,867 59,188 382 6,765 
ERR1726032 4.6G 15,288,191 14,959,449 222,760 396 31,300 
ERR1726033 11.5G 38,069,060 36,914,867 236,108 397 27,547 
ERR1726034 1.9G 6,416,235 6,078,322 107,287 386 15,425 
ERR1726035 4.8G 15,847,330 14,650,560 195,063 392 14,190 
ERR2592282 5.8G 19,303,711 18,088,371 232,720 393 38,612 
ERR2592343 13G 43,018,798 36,090,777 218,766 391 12,778 
       TOTAL (M) 56800      
TOTAL       65 Samples 280888.82 1,139,543,039 1,100,630,009 4,325,515         - - 
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Taxonomical Assignment  
  
To understand the dynamics of SM production in the different environments, 
this require to get the taxonomical assignment for the sequence reads of each sample. 
Samples were taxonomically classified on the sequence reads using Kraken 2 with the 
default taxonomy database. The abundance of the different taxonomic levels (species, 
genus, family, etc.) was estimated using Bracken. This exercise resulted into 
understanding the community structure and the abundance of each microbial group 
within each sample under test. Figure 5 showed how the relative abundance at genus 
level differ between samples of each projects, and it was clear that samples of some 
projects were dominated by few signature genera such as the sample of Osaka which 
were dominated mainly by Pseudomonas and Synechococcus. On the other hand, 
metagenomic skin samples of AD patients were dominated mainly by Cutibacterium, 
while Corynebacterium appeared like it stands alone in the samples of the Human skin 
metagenome from epithelium of external nose project (Nose).  
 
Figure 5. Barplot showing the relative abundance of all the detected microbial taxa, at the genus level, 
of the processed samples per each of the seven selected datasets. 
18 
 
To show how the different samples will be clustered based on the relative abundance of 
taxa we constructed both a PCA and t-SNE graphs (Figures 6 & 7). Projects like Osaka 
bay and water sewage appeared completely separated from the other five projects, while 
the rest shows some connections which mainly due to the presence of common genera, 
such as Corynebacterium and Cutibacterium which explained the presence of some 
samples from the Human skin metagenome from epithelium of external nose and Tonga 
trench project around the samples of the skin project of AD patients. These findings 
might be of great impact on understanding the dynamics of SM production in different 
environments. 
 
Figure 6. PCA analysis for the ecosystems, based on the assigned microbiome taxa. (A) Plot showing 
the most significant Principal Components, PC1, PC2 & PC3, all together represent 82% variations. (B) 
PCA biplot of the different samples from each of the seven selected datasets. PC1 & PC2 representing 
the most significant principle components and they cumulatively represent 68.7% and different samples 









Figure 7. t-SNE analysis for the datasets, based on the assigned microbiome taxa. 
BGC profile of samples in the dataset as detected by antiSMASH   
 
By using antiSMASH a total 776 BGCs regions were detected from the selected 
projects, 45 samples from 65 processed samples gave hits with antiSMASH (Figure 8). 
26 different BGC classes were detected (Figure 9), the seven major detected classes 
which collectively represent about 80% of the total detected BGCs classes were NRPS 
(23%), bacteriocin (15%), NRPS-like (10%), terpene (10%), sactipeptide (9%), 
arylpolyene (7%) and siderophore (5%). About 35% of the detected BGCs came from 
5 different bacterial genera, Pseudomonas contributed the most with 12% and it was 
obvious that the most dominant species was Pseudomonas sp. J380 which contributed 
alone by 10% of the total percentage of the detected BGCs. The genus Gordonia came 
in the second place with 8%, while the genus Corynebacterium produced 7% of the 
detected BGCs and both Cutibacterium and Blautia genera contributed by the same 
percentage of the detected BGCs, about 4% for each genus. To figure out the major 
differences between the processed samples from each environments in terms of BGCs 
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contents and their corresponding microbial contributors, we deeply analyzed the 
processed samples from each dataset and the results were explained in details here-
under. 
 
Figure 8. Distribution  of the detected BGCs by antiSMASH in all datasets (A) Distribution of 
the absolute number of the detected BGCs by antiSMASH (B) Distribution of the normalized 
percentages of the detected BGCs by antiSMASH. Percentages were normalized to the number 
of assembled bases per dataset.  
 
 
Figure 9. Distribution of the absolute number of the detected BGCs classes by antiSMASH in 
all datasets. 
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About 36.48%* (i.e. 101 BGCs) of the detected BGCs of 9 different classes 
were from the metatranscriptomic marine samples from Osaka Bay see water project. 
Only 6 samples out of 9 processed samples gave hits with antiSMASH pipeline. NRPS 
and bacteriocin represent the vast majority of the detected classes by 64%, NRPS class 
came in the first place by 44% while the percentage of the detected bacteriocin class 
was 20% and the percentages of the rest seven detected classes were as follows, 9% 
terpene, 7% NRPS-like, 7% arylpolyene, 5% hserlactone, 5% siderophore, 3% 
betalactone and only 1 BGC was NAGGN. 95% of the detected BGCs was produced 
by two genera, Pseudomonas and Synechococcus.  Pseudomonas contributed the most 
with 82% and it was obvious that the most dominant species was Pseudomonas sp. J380 
which contributed alone by 74% from the total percentage of the detected BGCs. 
Synechococcus came in the second place and contributed by 13% of the total detected 
classes. * Percentage was normalized to the total number of bases. 
 
 The results of metagenomic samples from the gut microbiome project of 
COVID-19 patients were analyzed. In this study, 10 samples were processed, all 
samples gave hits and antiSMASH detected 16 different BGCs classes with a total 
number of 243 BGCs. Only 5 classes out of 16 different classes, represent about 80% 
of the total detected classes as follows; 28% was sactipeptide, NRPS represent 19%, 
bacteriocin was 16%, arylpolyene and lanthipeptide represent 12% and 7% respectively. 
The rest of detected classes (11 classes) which collectively represent about 19% were, 
NRPS-like, terpene, T3PKS, lassopeptide, betalactone, resorcinol, siderophore, 
thiopeptide, nucleoside, butyrolactones and ladderane. About 43% of the detected 
BGCs were from 5 genera, 13% of BGCs was produced by Blautia, and 12% was from 
Lachnospiraceae, 7% was Bacteroides, 6% was Faecalibacterium and Streptococcus 
contributed with 5% of the detected BGCs.  
  
 Ten skin microbiome metagenomic samples were randomly chosen from a 
comparative metagenomic analysis study conducted in Singapore to assess the 
relationship between human skin microbiota stability and patients with atopic 
dermatitis. All samples gave hits with antiSMASH and it detected 19 different BGCs 
classes with a total number of 272 BGCs. Out of the 19 detected classes,  6 represent 
about 81% of the total number of the detected BGCs. These classes were NRPS, NRPS-
like, siderophore, terpene, bacteriocin and T1PKS which represent 27%, 17%, 10%, 
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10%, 9% and 8% respectively. The rest of detected classes (13 classes) which 
collectively represent about 19% were, ectoine, T3PKS, hserlactone, thiopeptide, 
betalactone, lanthipeptide, arylpolyene, CDPS, LAP, hglE-KS, ladderane, 
butyrolactones and lassopeptide. More than half of the detected BGCs (i.e. about 57%) 
were produced by 4 genera; Gordonia, Corynebacterium, Cutibacterium and 
Staphylococcus which represent 24%, 15%, 12% and 6% of the total detected BGCs                                                                        
respectively.  
 
 Five marine sediment metagenomic samples from Tonga trench sediment in the 
Pacific Ocean were processed by antiSMASH to screen for BGCs contents. Only 2 
samples gave hits and antiSMASH detected a total of 23 BGCs with 9 different classes. 
The detected classes with their corresponding percentages were as follows, (17%) 
arylpolyene, (17%) NRPS-like, (17%) hglE-KS, (13%) bacteriocin, (9%) phosphonate, 
(9%) terpene, (9%) hserlactone, (4%) T1PKS and (4%) NRPS. There was no much data 
about the microbial composition of the processed samples because antiSMASH could 
not assign about 43% of the detected BGCs to any microbial species.  
 
Another ten metagenomic samples from Mangrove sediment microbiome along 
South China were processed and 5 of them gave hits with antiSMASH. A total of 12 
BGCs with 6 different classes were detected. The detected classes with their 
corresponding percentages were as follows, (33%) bacteriocin, (17%) arylpolyene, 
(17%) NRPS-like, (17%) terpene, (8%) lassopeptide and (8%) NRPS. There was no 
much data about the microbial composition of the processed samples because 
antiSMASH could not assign about 58% of the detected BGCs to any microbial species. 
 
 Twelve samples were a Human skin metagenome from epithelium of external 
nose from a study conducted in Copenhagen; Denmark. Only 3 samples gave hits with 
antiSMASH and it was obvious that only one dominant genus, Corynebacterium 
produced 5 different classes of BGCs and a total 23 BGCs were detected as follows; 9 
NRPS representing 39%, 5 terpene (22%), 5 siderophore (22%), 2 NRPS-like (9%) and 
2 T1PKS (9%). There was no much data about the microbial composition of the 
processed samples because antiSMASH could not assign about 53% of the detected 
BGCs to any microbial species. 
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 The last 9 samples were from the Global Sewage Project. A total of 102 BGCs 
with 12 different classes were detected. The detected BGCs classes with their 
corresponding percentages were as follows, (30%) bacteriocin, (28%) terpene, (10%) 
hserlactone, (8%) NRPS-like, (7%) arylpolyene, (5%) sactipeptide, (3%) resorcinol, 
(3%) T3PKS, (2%) ectoine, (2%) butyrolactones, (1%) phenazine and (1%) RaS-RiPP.  
Almost 50% of the produced BGCs was from 3 major genera; Streptococcus comes in 
the first place with 27%, Neisseria produced about 15% and 6% was from Polaromonas. 
What is interesting about this project is that there are few unique BGCs classes detected 
by antiSMASH which are not appear in the previous 6 projects, such as resorcinol, 
ectoine, phenazine and RaS-RiPP. Moreover, these classes are not produced by the 
dominant genera (i.e. resorcinol is produced either by Brevundimonas or 
Pasteurellaceae, ectoine produced by Arcobacter and phenazine was produced by 
Escherichia coli) each genera represent only about 1% of the total microbial 
community. We discussed this point with some details elsewhere in this study.   
 
BGC profile of samples in the dataset as detected by DeepBGC  
 
 Before we decide to use deepBGC pipeline, we did a pilot trial to test deepBGC 
output and the results were very interesting and rich with huge amount of data compared 
to antiSMASH. Although it is not an objective of this study to perform a comparative 
analysis between the results obtained by both pipelines, however, we decide to use 
deepBGC to get a deeper insight and grasp more information about the processed 
samples and their corresponding communities.  
 
For a better understanding of deepBGC results here are some important points 
about this algorithm. The current deepBGC pipeline could detects only six different 
BGCs classes, five specific (i.e. Polyketide, NRP, RiPP, Saccharide and Terpene) and 
one unspecific annotated by the algorithm as “other”. In addition to the huge amount of 
data generated by deepBGC there is another major advantage of it because it could 
assign four different products’ activities (i.e. antibacterial, antifungal, inhibitor and 
cytotoxic) to each detected BGCs with a very high coverage percentage, almost 96% of 
processed samples. We tried to figure out the annotation mechanism of deepBGC, we 
discovered that there is a scoring system for both class and product activity annotations, 
the pipeline assigned class and activity for hits with scores ≥ 0.5 and if there are more 
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than one class or activity with a score ≥ 0.5, all will be annotated to the same hit, 
separated by a hyphen sign (-).  
 
Unlike antiSMASH, deepBGC detected large number of BGCs classes and a 
total 79,771 BGCs were detected from the selected datasets (Figure 10), moreover all 
the 65 samples gave hits. DeepBGC assigned BGCs classes to around 20% of hits 
(15,714 hits) as follows; 39% of hits was Polyketide, 18% RiPP, 18% Saccharide, 10% 
others, 7% NRP, 4% Terpene, 2% Polyketide-Terpene, 1% NRP-Polyketide and 1% 
Saccharide-Terpene (Figure 11).  
 
Figure 10. Distribution  of the detected BGCs by deepBGC in all datasets (A) Distribution of 
the absolute number of the detected BGCs by deepBGC (B) Distribution of the normalized 
percentages of the detected BGCs by deepBGC. Percentages were normalized to the number 




Figure 11. Distribution of the absolute number of the detected BGCs classes by deepBGC in 
all datasets. 
A major advantage of deepBGC is that it could assign product activity to each single 
detected BGC class with a very high coverage rate. In this study deepBGC assigned 
product activity to 96% of the hits and the results were 97% of hits have an antibacterial 
activity, 1% inhibitor, 1% antibacterial-antifungal and less than 1% cytotoxic (Figure 
12). About 31% of the detected BGCs were products of microbial species belong to one 
of the following eight genera, 7% from Bacteroides, 5% Pseudomonas, 5% 
Corynebacterium, 4% Gordonia, 3% Blautia, 3% Escherichia, 2% Faecalibacterium 
and 2% Cutibacterium. 
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Figure 12. Distribution the assigned product activities by deepBGC in all datasets. (A) 
Distribution of the absolute number of the assigned products’ activities by deepBGC (B) 
Distribution of the normalized percentages of the assigned products’ activities by deepBGC. 
Percentages were normalized to the number of assembled bases per dataset. 
DeepBGC detected 4,795 BGCs from the nine metatranscriptomic marine samples from 
Osaka Bay see water project. All processed samples gave hits with deepBGC pipeline. 
DeepBGC assigned BGCs classes to around 17% of the hits (832 hits) as follows; 49% 
of hits was Polyketide, 13% NRP, 12% RiPP, 8% other, 7% Saccharide, 6% Terpene, 
3% Saccharide-Terpene, 2% Polyketide-Terpene and 1% NRP-Polyketide. In this 
project deepBGC assigned product activity to almost 96% of the hits and the results 
were 97% of hits have an antibacterial activity, 2% inhibitor and 1% antibacterial-
antifungal. DeepBGC specified the microbial species to about 82% of the hits and more 
than 80% of the detected BGCs were products of microbial species belong to one of the 
following 3 genera, 63% from Pseudomonas, 15% Synechococcus, and 4% Candidatus. 
 
The results of metagenomic samples from the gut microbiome project of 
COVID-19 patients were analyzed. In this study, 10 samples were processed, all 
samples gave hits and deepBGC annotated BGCs classes to around 20% of the hits 
(6,852 hits) as follows; 30% of hits was Polyketide, 26% Saccharide, 23% RiPP, 11% 
other, 4% NRP, 3% Terpene, 1% Polyketide-Terpene and 1% NRP-Polyketide. In this 
project deepBGC assigned product activity to almost 96% of the hits and the results 
were 98% of hits have an antibacterial activity, 1% inhibitor, 1% antibacterial-
antifungal and 1% cytotoxic. DeepBGC specified the microbial species to about 79% 
of the hits and about 33% of the detected BGCs were products of microbial species 
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belong to one of the following 4 genera, 16% from Bacteroides, 7% Blautia, more than 
5% Lachnospiraceae and 5% Faecalibacterium. 
A total of 18,683 hits were detected by deepBGC from 10 skin microbiome 
metagenomic samples of patients with atopic dermatitis. DeepBGC annotated BGCs 
classes to around 22% of the hits (4,137 hits) as follows; 46% of hits was Polyketide, 
14% RiPP, 10% Saccharide, 10% NRP, 8% Other, 5% Terpene, 5% Polyketide-
Terpene, 2% Saccharide-Terpene and 1% NRP-Polyketide. Moreover, deepBGC 
assigned product activity to almost 95% of the hits and 96% of hits have an antibacterial 
activity, 2% inhibitor and 2% antibacterial-antifungal. DeepBGC specified the 
microbial species to about 75% of the hits and more than 50% of the detected BGCs 
were products of microbial species belong to one of the following 5 genera, 16% from 
Gordonia, 14% Corynebacterium, 7% Mycolicibacterium, 7% Cutibacterium and 7% 
Micrococcus. 
The five samples from Tonga trench project gave 2,751 hits with deepBGC. The 
pipeline annotated about 21% of these hits (567 hits) with different BGCs classes as 
follow; 52% of hits belonged to Polyketide, 12% RiPP, 11% Terpene, 8% Others, 7% 
NRP, 5% Saccharide, 4% Polyketide-Terpene, 1% Saccharide-Terpene and 1% NRP-
Polyketide. On the other hand, 96% of hits annotated by deepBGC with three different 
activities, the majority about 96% have an antibacterial activity, 3% antibacterial-
antifungal and about 1% inhibitor. The pipeline also specified the microbial species to 
about 45% of the hits and about 20% of the detected BGCs were products of microbial 
species belong to one of the following 2 genera, 16% Cutibacterium and 4% belonged 
to Pseudomonas. 
 
The then metagenomic samples from Mangrove sediment microbiome project 
gave 1,624 hits with deepBGC. The pipeline annotated about 14% of these hits (230 
hits) with different BGCs classes as follow; 46% of hits belonged to Polyketide, 13% 
Saccharide, 11% NRP, 9% RiPP, 8% Others, 6% Terpene, 5% Polyketide-Terpene and 
1% Saccharide-Terpene. On the other hand, 97% of the total detected hits annotated by 
deepBGC with one of two different activities, the vast majority about 99% have an 
antibacterial activity and 1% inhibitor. The pipeline also specified the microbial species 
to about 52% of the hits and about 24% of the detected BGCs were products of microbial 
species belong to one of the following 3 genera, 10% Altererythrobacter, 8% 
Erythrobacter and 6% belonged to Candidatus Plagibacter. 
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The twelve metagenomic samples from a study conducted in Copenhagen; 
Denmark gave about 1,351 hits with deepBGC. The pipeline annotated about 21% of 
these hits (283 hits) with different BGCs classes as follow; 45% of hits belonged to 
Polyketide, 17% RiPP, 12% Other, 9% NRP, 8% Saccharide, 7% Terpene, 1% 
Polyketide-Terpene and 1% NRP-Polyketide. Moreover, about 95% of the total 
detected hits annotated by deepBGC with one of three different activities, the vast 
majority, about 96%, have an antibacterial activity, 2% inhibitor and 1% antibacterial-
antifungal. The pipeline also specified the microbial species to about 81% of the hits 
and the genus Corynebacterium was the most dominant as it represents about 78% of 
the whole microbial community from the processed samples.  
 
The last 9 samples were from the Global Water Sewage Project. DeepBGC 
pipeline gave 16,682 hits, 17% of it (i.e. 2,813 hits) annotated by deepBGC with 
different BGCs classes. The majority 44% were Polyketide, 17% RiPP, 15% 
Saccharide, 12% Other, 5% NRP, 4% Terpene, 2% Polyketide-Terpene, 1% NRP-
Polyketide. The pipeline assigned product activity to almost 97% of the total hits and 
the vast majority, 97%, was antibacterial, 1% was inhibitor and 1% was antibacterial-
antifungal. DeepBGC specified the microbial species to about 77% of the hits and about 
31% of the detected BGCs were products of microbial species belong to one of the 
following 6 genera, 9% Escherichia, 6% Acidovorax, 5% Neisseria, 4% Streptococcus, 
3% Arcobacter and the last 3% belonged to Pseudomonas. 
 
AMR genes profile of samples in the dataset as detected by CARD’s RGI 
 
The second major goal of this study was to detect the antimicrobial resistance 
genes of the samples from the selected metagenomes, along with their mechanisms of 
actions and the drug classes which it confers resistance to. Here we used Resistance 
Gene Identifier (RGI) algorithm from The Comprehensive Antibiotic Resistance 
Database (CARD) with the following criterions for detection (perfect, strict & loose, 
partial genes included, 95% identity nudge used) of AMR genes. Loose hits were 
excluded, here only results of perfect and strict hits were reported to ensure that they 
are either perfect matches or passed the curated bit-score. In our study, the selected sixty 
five samples from the different seven selected projects were analyzed by CARD’s RGI 
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and a total number of around 1216 AMR gene families were detected which confer 
resistance to about 2602 drug classes by 1163 resistance mechanisms. Figures 18 – 20 
show the distribution of the detected AMR gene families, drug classes and resistance 
mechanisms of all samples from the seven selected metagenomes, respectively. Gut 
microbiome of COVID-19 patients’ samples and water sewage samples represent more 
than 70% of antibiotic resistance abundance, while samples of the rest five selected 
metagenomes represent less than 30%.  To eliminate the effect of the number of bases 
all percentages were normalized by dividing the total detected number of AMR gene 
families, drug classes and resistance mechanisms by the total number of used bases per 
each of the seven selected metagenomes.  
 
Figure 13. Distribution the detected AMR genes families by CARD in all datasets. (A) 
Distribution of the absolute number of detected AMR genes families by CARD. (B) Distribution 
of the normalized percentages of the detected AMR genes families. Percentages were 
normalized to the number of assembled bases per dataset. 
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Figure 14. Distribution the detected drug classes by CARD in all datasets. (A) Distribution of 
the absolute number of detected drug classes by CARD. (B) Distribution of the normalized 
percentages of the detected drug classes. Percentages were normalized to the number of 
assembled bases per dataset. 
 
Figure 15. Distribution the detected resistance mechanisms by CARD in all datasets. (A) 
Distribution of the absolute number of detected resistance mechanisms by CARD. (B) 
Distribution of the normalized percentages of the detected resistance mechanisms. Percentages 
were normalized to the number of assembled bases per dataset. 
The results of metagenomic samples from the gut microbiome project of COVID-19 
patients were analyzed. In this study, 10 samples were processed, 9 samples gave 
perfect hits (76 hits) while all samples gave strict hits (468 hits). CARD’s RGI algorithm 
detected a total of 608 AMR genes from different 55 families which represent 48.26% 
of all detected AMR gene families of all processed samples from the seven selected 
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metagenomes. Such AMR genes confer resistance to a total of 1378 drugs from different 
37 classes which represent 51.51% of the overall results (Table 5).  
Table 5. Drug classes detected by CARD's RGI in gut microbiome of COVID-19 patients’ samples. A 
total 1378 drug classes from 32 different classes, according to CARD’s classification were detected. 
# Drug Classes Detected # % 
1 tetracycline antibiotic 203 14.73% 
2 fluoroquinolone antibiotic 174 12.63% 
3 Penam 118 8.56% 
4 Cephalosporin 105 7.62% 
5 macrolide antibiotic 95 6.89% 
6 aminoglycoside antibiotic 73 5.30% 
7 rifamycin antibiotic 69 5.01% 
8 phenicol antibiotic 59 4.28% 
9 glycylcycline 49 3.56% 
10 lincosamide antibiotic 44 3.19% 
11 Cephamycin 43 3.12% 
12 peptide antibiotic 42 3.05% 
13 Triclosan 42 3.05% 
14 aminocoumarin antibiotic 34 2.47% 
15 streptogramin antibiotic 32 2.32% 
16 Carbapenem 23 1.67% 
17 Penem 23 1.67% 
18 diaminopyrimidine antibiotic 20 1.45% 
19 nucleoside antibiotic 20 1.45% 
20 acridine dye 19 1.38% 
21 Monobactam 17 1.23% 
22 Fosfomycin 16 1.16% 
23 glycopeptide antibiotic 16 1.16% 
24 nitrofuran antibiotic 7 0.51% 
25 nitroimidazole antibiotic 6 0.44% 
26 oxazolidinone antibiotic 6 0.44% 
27 pleuromutilin antibiotic 6 0.44% 
28 benzalkonium chloride 5 0.36% 
29 Rhodamine 5 0.36% 
30 elfamycin antibiotic 4 0.29% 
31 aminocoumarin antibiotic 2 0.15% 
32 sulfonamide antibiotic 1 0.07% 
GRAND TOTAL 1378 100.00% 
 
These genes confer resistance to the different drug classes by 6 different 
resistance mechanisms of a total 580 mechanisms, which represent 48.68% of the 
overall detected resistance mechanisms. The top three detected AMR gene families 
were, resistance-nodulation-cell division (RND) antibiotic efflux pump (28.62%), 
major facilitator superfamily (FS) antibiotic efflux pump (17.11%) and tetracycline-
resistant ribosomal protection protein (10.36%), which represent 56.09% of the 608 
detected AMR gene families. Whereas, the top first five drug classes which represent 
50.44% of the detected 1378 drug classes were as follows, tetracycline antibiotic 
(14.73%), fluoroquinolone antibiotic (12.63%), penam (8.56%), cephalosporin (7.62%) 
and macrolide antibiotic (6.89%). On the other hand, the six detected resistance 
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mechanisms by which genes introduce drug resistance, were as follows; antibiotic 
efflux (47.93%), antibiotic target alteration (20%), antibiotic inactivation (13.28%), 
antibiotic target protection (12.24%), antibiotic target replacement (3.97%) and reduced 
permeability to antibiotic (2.59%). 
 
The nine metagenomic samples from the Global Water Sewage Project come in 
the second place after gut microbiome of COVID-19 patients’ samples in terms of 
antibiotic resistance abundance. All samples gave hits with RGI where; 96 of hits were 
perfect matches and 370 of the hits were strict. A total 506 AMR genes belong to 37 
different families was detected, which represent 23.37% of all detected AMR gene 
families. These genes confer resistance to 1031 drugs belong to 29 different classes 
which collectively represent 22.42% of the whole detected drug classes (Table 6).  
 
Table 6. Drug classes detected by CARD's RGI in water sewage samples. A total 1031 drug classes 
from 29 different classes, according to CARD’s classification were detected. 
# Drug Classes Detected # % 
1 tetracycline antibiotic 155 15.03% 
2 Penam 123 11.93% 
3 fluoroquinolone antibiotic 103 9.99% 
4 macrolide antibiotic 90 8.73% 
5 Cephalosporin 87 8.44% 
6 aminoglycoside antibiotic 77 7.47% 
7 phenicol antibiotic 49 4.75% 
8 Cephamycin 37 3.59% 
9 rifamycin antibiotic 35 3.39% 
10 Glycylcycline 30 2.91% 
11 Triclosan 29 2.81% 
12 aminocoumarin antibiotic 25 2.42% 
13 peptide antibiotic 22 2.13% 
14 sulfonamide antibiotic 20 1.94% 
15 acridine dye 18 1.75% 
16 nucleoside antibiotic 17 1.65% 
17 diaminopyrimidine antibiotic 15 1.45% 
18 lincosamide antibiotic 15 1.45% 
19 streptogramin antibiotic 15 1.45% 
20 Monobactam 14 1.36% 
21 Penem 14 1.36% 
22 oxazolidinone antibiotic 9 0.87% 
23 pleuromutilin antibiotic 9 0.87% 
24 Carbapenem 7 0.68% 
25 nitroimidazole antibiotic 5 0.48% 
26 Fosfomycin 4 0.39% 
27 Carbapenem 3 0.29% 
28 benzalkonium chloride 2 0.19% 
29 Rhodamine 2 0.19% 




These genes confer resistance to the different drug classes by 6 different 
resistance mechanisms of a total 487 mechanisms, which represent 23.78% of the 
overall detected resistance mechanisms. Three major AMR gene families which 
represent 55.73% of 506 detected AMR genes were as follows; major facilitator 
superfamily (MFS) antibiotic efflux pump (24.90%), resistance-nodulation-cell 
division (RND) antibiotic efflux pump (20.75%) and tetracycline-resistant ribosomal 
protection protein (10.08%). Out of the 29 different drug classes, there were 6 major 
classes which represent 61.59% from the total number of 1031 detected drugs, and they 
were as follows; tetracycline antibiotic (15.03%), penam (11.93%), fluoroquinolone 
antibiotic (9.99%), macrolide antibiotic (8.73%), cephalosporin (8.44%) and 
aminoglycoside antibiotic (7.47%). As in gut microbiome of COVID-19 patients’ 
samples, there were six different resistance mechanisms detected but with different 
percentages as follows; antibiotic efflux (45.38%), antibiotic inactivation (27.72%), 
antibiotic target protection (13.14%), antibiotic target replacement (6.78%), antibiotic 
target alteration (6.37%) and reduced permeability to antibiotic (0.62%). 
 
The results of the rest five selected metagenomes represent less than 30% 
(normalized value) in terms of AMR gene family, drug classes and resistance 
mechanisms. No perfect hits were detected from the nine metatranscriptomic marine 
samples from Osaka Bay see water project while there were 26 strict hits from 5 samples 
detected. A total of 36 AMR genes from different 5 families which represent 15.35% 
of all detected AMR gene families of all processed samples from the seven selected 
metagenomes. The detected AMR genes confer resistance to a total of 77 drugs from 
different 11 classes which represent 15.46% of the overall results (Table 7).  
 
Table 7. Drug classes detected by CARD's RGI in Osaka bay samples.  A total 77 drug classes from 11 
different classes, according to CARD’s classification were detected. 
# Drug Classes Detected # % 
1 aminoglycoside antibiotic 10 12.99% 
2 fluoroquinolone antibiotic 15 19.48% 
3 tetracycline antibiotic 15 19.48% 
4 triclosan 6 7.79% 
5 cephalosporin 5 6.49% 
6 glycylcycline 5 6.49% 
7 penam 5 6.49% 
8 acridine dye 5 6.49% 
9 rifamycin antibiotic 5 6.49% 
10 phenicol antibiotic 5 6.49% 
11 macrolide antibiotic 1 1.30% 
GRAND TOTAL 77 100.00% 
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The detected AMR genes confer resistance to the different drug classes by 3 
different resistance mechanisms of a total 31 mechanisms, which represent 13.98% of 
the overall detected resistance mechanisms. The five detected AMR gene families were, 
resistance-nodulation-cell division (RND) antibiotic efflux pump (41.67%), major 
facilitator superfamily (MFS) antibiotic efflux pump (16.67%), APH(3'') (13.89%), 
APH(6) (13.89%) and ATP-binding cassette (ABC) antibiotic efflux pump (13.89%), 
which all represents 14.52% of the 36 detected AMR gene families. However, the first 
major three drug classes which represent 51.95% of the 77 detected drug classes were 
as follows, tetracycline antibiotic (19.48%), fluoroquinolone antibiotic (19.48%) and 
aminoglycoside antibiotic (12.99%). The three detected resistance mechanisms by 
which genes introduce drug resistance, were as follows; antibiotic efflux (51.61%), 
antibiotic inactivation (32.26%) and antibiotic target alteration (16.13%).  
On the other hand, from the ten samples of Skin AD metagenomes, only 4 
samples gave 7 perfect hits whereas all samples gave strict hits and the total detected 
number was 53 hits. The processed samples yielded a total number of 61 AMR genes 
from different 25 families which represent 12.53% of all detected AMR gene families 
compared to the rest of samples from the seven selected projects. These AMR genes 
confer resistance to a total of 101 drugs from different 23 classes which represent 9.77% 
of the overall results (Table 8).  
Table 8. Drug classes detected by CARD's RGI in skin AD patients’ samples.  A total 101 drug classes 
from 23 different classes, according to CARD’s classification were detected. 
# Drug Classes Detected # % 
1 aminoglycoside antibiotic 15 14.85% 
2 macrolide antibiotic 11 10.89% 
3 lincosamide antibiotic 11 10.89% 
4 streptogramin antibiotic 11 10.89% 
5 fluoroquinolone antibiotic 9 8.91% 
6 phenicol antibiotic 7 6.93% 
7 Penam 6 5.94% 
8 tetracycline antibiotic 5 4.95% 
9 peptide antibiotic 4 3.96% 
10 oxazolidinone antibiotic 3 2.97% 
11 pleuromutilin antibiotic 3 2.97% 
12 fusidic acid 2 1.98% 
13 lincosamide antibiotic 2 1.98% 
14 diaminopyrimidine antibiotic 2 1.98% 
15 acridine dye 2 1.98% 
16 aminocoumarin antibiotic 1 0.99% 
17 elfamycin antibiotic 1 0.99% 
18 Cephalosporin 1 0.99% 
19 Fosfomycin 1 0.99% 
20 glycopeptide antibiotic 1 0.99% 
21 Mupirocin 1 0.99% 
22 rifamycin antibiotic 1 0.99% 
23 sulfonamide antibiotic 1 0.99% 
GRAND TOTAL 101 100.00% 
 
35 
The detected AMR genes confer resistance to the different drug classes by 5 
different resistance mechanisms of a total 60 mechanisms, which represent 13.03% of 
the overall detected resistance mechanisms. The most abundant detected AMR gene 
families which represent 52.46% of all detected AMR genes were as follows, major 
facilitator superfamily (MFS) antibiotic efflux pump (18.03%), Erm 23S ribosomal 
RNA methyltransferase (13.11%), blaZ beta-lactamase (8.20%), APH(3'') (6.56%) and 
APH(6) (6.56%). However, the first major five drug classes which represent 56.44% of 
the 101 detected drug classes were as follows, aminoglycoside antibiotic (14.85%), 
macrolide antibiotic (10.89%), lincosamide antibiotic (10.89%), streptogramin 
antibiotic (10.89%) and fluoroquinolone antibiotic (8.91%). While the five detected 
resistance mechanisms by which genes introduce drug resistance, were as follows; 
antibiotic inactivation (35%), antibiotic target alteration (28.33%), antibiotic efflux 
(23.33%), antibiotic target protection (10%) and antibiotic target replacement (3.33%). 
 
The next samples from the last three selected metagenomes represent the 
smallest fraction of all results. Their combined results gave less than 1% compared to 
the rest of results. No perfect hits were detected and only few strict hits were reported 
as follows, 3 hits, 1 hit and 1 hit from Nose, Tonga and Mangrove projects, respectively. 
These results reflect a few number of detected AMR gene families (i.e. 3, 1 and 1 for 
each projects on the same stated order, Nose, Tonga and Mangrove), which represent 
only 0.49% from the whole results. The detected AMR gene families were as follows, 
3 Erm 23S ribosomal RNA methyltransferase, 1 TEM beta-lactamase and 1 resistance-
nodulation-cell division (RND) antibiotic efflux pump for samples of Nose, Tonga and 
Mangrove projects, respectively. Regarding the detected drug classes, we reported a 
total of 15 drug classes from the three projects, Nose samples came in the first place by 
9 classes, then Tonga with 4 classes and last place was for Mangrove samples with only 
2 classes. These 15 drug classes represent 0.84% from the overall results (Tables 9 – 
11). The nine drug classes of Nose project were from three different classes, macrolide 
antibiotic, lincosamide antibiotic and streptogramin antibiotic which share the same 
percentage 33%. While the four detected drug classes of Tong project were from four 
different classes as follows; monobactam, cephalosporin, penam and penem. We also 
reported only 2 drug classes from samples of Mangrove project as follows; 
fluoroquinolone antibiotic and tetracycline antibiotic. Five resistance mechanisms, 
represent 0.52%, were also reported from the three projects, 3 from Nose, 1 from Tonga 
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and 1 from Mangrove. These five mechanisms belong to three different types as 
follows; antibiotic target alteration, antibiotic inactivation and antibiotic efflux for 
Nose, Tonga and Mangrove metagenomes, respectively.  
 
Table 9. Drug classes detected by CARD's RGI in nose samples.  A total 9 drug classes from 3 
different classes, according to CARD’s classification were detected. 
# Drug Classes Detected # % 
1 macrolide antibiotic 3 33% 
2 lincosamide antibiotic 3 33% 
3 streptogramin antibiotic 3 33% 
GRAND TOTAL 9 100.00% 
 
Table 10. Drug classes detected by CARD's RGI in Tonga trench samples.  A total 4 drug classes from 
4 different classes, according to CARD’s classification were detected. 
# Drug Classes Detected # % 
1 Monobactam 1 25% 
2 Cephalosporin 1 25% 
3 Penam 1 25% 
4 Penem 1 25% 
GRAND TOTAL 4 100.00% 
 
Table 11. Drug classes detected by CARD's RGI in Mangrove samples.  A total 2 drug classes from 2 
different classes, according to CARD’s classification were detected. 
# Drug Classes Detected # % 
1 fluoroquinolone antibiotic 1 50% 
2 tetracycline antibiotic 1 50% 























Chapter 4: Discussion  
 
According to WHO, antimicrobial resistance is considered one of the most 
complex global health challenges and should be a political priority. Dr Chan, WHO 
Former Director-General, said "The World Bank has warned that antimicrobial 
resistance could cause as much damage to the economy as the 2008 financial crisis." 
Moreover, with the limited choices of replacement products, WHO experts expect that 
the world is heading toward a post antibiotic era and the common infectious diseases 
will be mortal once again. This put a great pressure on the scientific community all over 
the world to discover new classes of antibiotics with new mechanisms of actions against 
the rising number of antimicrobial resistant bacterial strains.  
Over the third of small molecule medicines approved by the FDA were microbial 
natural products encoded by neighboring genes called Biosynthetic Gene Clusters 
(BGCs) (Newman & Cragg, 2020 & Martin, 1992). To date, the gold standard way for 
discovering bioactive natural products is the culture-dependent techniques which 
considered a major challenge due to the fact that only small fraction of bacterial species 
could be cultured under the current laboratory conditions (Stewart, 2012). The 
advancement of sequencing technologies and omics approaches unleash the power of 
natural products discovery through exploring the uncultivated microbial species which 
represent the biggest fraction of microbial community.  Here we tried to positively 
contribute in solving the antimicrobial resistance problem by two different ways. 
Firstly, we tried to support researchers who interested in natural products discovery 
through catalog the bacterial BGCs in the selected metagenomes by conducting a 
comparative analysis to determine the different BGCs’ classes present in each of the 
selected samples along with highlighting the major bacterial species contributors. 
Secondly, we did a thorough analysis to detect the antimicrobial resistance genes with 
their resistance mechanisms along with the drug classes they confer resistance to, in 
order to shed the light on this crises with deeper insights.  
Different environments have different microbial taxa profile  
Each environments comprise huge microbial communities live in complex 
interactions that greatly impact our life. Therefore, such comparative studies aiming to 
precisely profile the microbial communities’ compositions and their corresponding 
contributions in terms of production of secondary metabolites, are of fundamental 
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interest. Our results show that the different environmental conditions are the major 
determinants of the microbial composition. By screening 65 samples from seven 
different metagenomic and metatranscriptomic projects we discovered reads belong to 
a wide range of different microbial taxa, at the genus level, and some of them was found 
to be unique and characteristic to their corresponding environments. For example, 
samples from Osaka bay project were characterized by the presence of three major 
genera, in terms of their BGC contribution, the first place goes to Pseudomonas which 
contribute alone by more than 60% of the detected BGCs, Synechococcus comes in the 
second place by more than 15% while the third place goes to Candidatus Plagibacter 
by about 4% of the detected BGCs. Moreover, Synechococcus was not recognized in 
any other samples from the other 6 projects therefor it was unique and characteristic to 
this environment at the time of sampling. Mangrove samples, on the other hand, were 
characterized by the presence of two unique genera which not reported elsewhere in our 
study, Altererythrobacter and Erythrobacter which contributed by about 10% and 8% 
of the detected BGCs respectively. Candidatus, which appeared to be characteristic also 
to Osaka bay environment, comes here in the third place contributing by about 6% of 
the detected BGCs (Figure 16). 
 
Figure 16. Distribution of the number of contributed genus to BGCs with their respective 
contribution percentages as assigned by antiSMASH per dataset. 
39 
Table 12 has a complete comparison between antiSMASH and deepBGC results in 
terms of the detected BGC classes with their corresponding percentages and the most 
abundant genera with their contributions’ percentages. It was obvious that each 
environment had a signature microbial taxa profile, at the time of sampling, in terms of 
the relative abundance and sometimes there is a unique genera specific to each particular 
environments. In Tonga trench samples two genera were contributed the most to the 
detected BGCs, Cutibacterium (~16%) and Pseudomonas (~4%) while Shewanella was 
unique to this environment, although, it present in a relatively low abundance it survived 
and this case and other similar cases will be explained with some details in the next 
sections.  
Table 12. Comparison between antiSMASH and deepBGC in terms of the detected BGCs’ classes with their 
corresponding percentage and the most abundant genera with their percentage of contribution. 
Projects 
antiSMASH deepBGC 
BGC classes % Genus % BGC classes % Genus % 
Osaka 
Bay 
NRPS 44% Pseudomonas 82% Polyketide 49% Pseudomonas 63% 







Arylpolyene 7% Other 8% 
  
NRPS-like 7% Saccharide 7% 















sactipeptide 28% Blautia 13% Polyketide 30% Bacteroides 16% 
NRPS 19% Lachnospiraceae 12% Saccharide 26% Blautia 7% 
bacteriocin 16% Bacteroides 7% RiPP 23% Lachnospiraceae 5% 
arylpolyene 12% Faecalibacterium 6% Other 11% Faecalibacterium 5% 
lanthipeptide 7% Streptococcus 5% NRP 4%   












Betalactone 2%   








NRPS 27% Gordonia 24% Polyketide 46% Gordonia 16% 
NRPS-like 17% Corynebacterium 15% RiPP 14% Corynebacterium 14% 
Siderophore 10% Cutibacterium 12% Saccharide 10% Mycolicibacterium 7% 
Terpene 10% Staphylococcus 6% NRP 10% Cutibacterium 7% 
Bacteriocin 9%   Other 8% Micrococcus 7% 






















Arylpolyene 17% Shewanella 




NA Polyketide 52% Cutibacterium 16% 
NRPS-like 17%  RiPP 12% Pseudomonas 4% 
hglE-KS 17%  Terpene 11%   
Bacteriocin 13%  Other 8%   
phosphonate 9%  NRP 7%   














Bacteriocin 33% - - Polyketide 46% Altererythrobacter 10% 
Arylpolyene 17%   Saccharide 13% Erythrobacter 8% 
NRPS-like 17% NRP 11% 
Candidatus 
Plagibacter 6% 
Terpene 17% RiPP 9%   
lassopeptide 8% Other 8% 















Terpene 22%   RiPP 17%   
Siderophore 22% Other 12% 
NRPS-like 9% NRP 9% 
T1PKS 9% Saccharide 8% 






Bacteriocin 30% Streptococcus 27% Polyketide 44% Escherichia 9% 
Terpene 28% Neisseria 15% RiPP 17% Acidovorax 6% 
hserlactone 10% Polaromonas  6% Saccharide 15% Neisseria 5% 
NRPS-like 8%   Other 12% Streptococcus 4% 
arylpolyene 7% NRP 5% Arcobacter 3% 
















It was expected that similar environments in terms of their nature, most probably 
would have similar microbial composition. This was reported in our study as follows, 
samples from two different skin environments were addressed; samples of the Human 
skin metagenome from epithelium of external nose project were characterized and 
dominated by Corynebacterium while the samples from metagenomic skin of patients 
with AD were characterized by the following genera, Corynebacterium and 
Cutibacterium. Here Corynebacterium was the first contributors in both skin 
environments by more than 75% and about 14% of the detected BGCs in nose & skin 
AD samples respectively. Cutibacterium comes in the second place in terms of BGCs 
contribution by about 7% in skin AD patients samples and this might be due to an arm 
race between Corynebacterium and Cutibacterium and both genera were trying to create 
their own niche at the time of sampling. Three water in nature environments, Osaka, 
Tonga and Sewage, also were characterized by the presence of Pseudomonas genera 
with a high relative abundance in Osaka bay and very low abundance in both Tonga and 
Sewage samples. Moreover, samples from both COVID-19 patients and sewage 
represent gut microbiome community and this could explain the presence of 
Streptococcus genera in both samples. The Barplot in Figure 4 in results section, 
showing the relative abundance of all the detected microbial taxa, at the genus level, of 
the 65 processed samples per each of the seven selected projects.  
Our analysis also shows that there might be common bacterial strains between 
irrelevant environments, such as the presence of Cutibacterium in samples from both 
skin AD patients and Tonga trench. Moreover, we reported the presence of Candidatus 
in both samples from Osaka bay and Mangrove with relatively low abundance in both. 
To show how the different samples will be clustered based on the relative abundance of 
taxa we constructed both a PCA and t-SNE graphs (Figures 5 & 6 in results section). 
Projects like Osaka bay and water sewage which dominated by Pseudomonas and 
Streptococcus respectively with a high abundance, appeared completely separated from 
the rest five projects, while there were many connections between the other projects, 
which mainly due to the presence of common genera, such as Corynebacterium and 
Cutibacterium which explained the presence of some samples, appeared on both figures 
as colored dots, from the Human skin metagenome from epithelium of external nose 
and Tonga trench project around the samples of the skin project of AD patients (Table 
12).  
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It was also obvious that samples of some projects were dominated by few unique 
genera such as the samples from Osaka bay project which were dominated mainly by 
Pseudomonas with very large percentage followed by Synechococcus with relatively 
high percentage. Moreover, samples from the project of metagenomic skin of patients 
with AD were dominated mainly by Cutibacterium which is characteristic to skin 
environment, while Corynebacterium stands alone in the samples of the Human skin 
metagenome from epithelium of external nose project. Species like Streptococcus 
agalactiae were unique and characteristic to the samples of the water sewage projects. 
Although Streptococcus agalactiae present in a very low abundance it survived at the 
time of sampling. To understand the reason behind the presence of different microbial 
profiles in each environments, where some genera stands alone in some samples while 
there are samples with many different species live together and how could some species 
survive with a very low abundance, we analyzed the microbial biosynthetic potential of 
each environment on the next section.  
The biosynthetic potential of the selected microbial metagenomes  
 The importance of secondary metabolites came from their potential applications, 
as assigned by deepBGC the vast majority, about 95%, of the detected BGCs have an 
antibacterial activity. According to antiSMASH results, 45 out of 65 samples from the 
seven selected projects give hits of a total 776 BGCs regions of different 26 classes. We 
found that the number of BGCs and their classes directly proportional with the degree 
of microbial diversity (Figure 17).  
 
Figure 17. Distribution absolute number the different BGCs classes detected by antiSMASH per 
dataset. 
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Environments with a high degree of microbial diversity such as skin AD, gut 
microbiome of COVID-19 patients and sewage were very rich in terms of total number 
of detected BGCs and also in the number of BGCs’ classes. Ten samples from skin AD 
come in the first place with 272 detected BGCs belong to 19 different classes with 2 
unique classes (i.e. CDPS & LAP) which not reported elsewhere in our study. About 
57% of the detected BGCs belongs to four genera, Gordonia, Corynebacterium, 
Cutibacterium and Staphylococcus. There might be an arm race between these genera 
and each one trying to use as many weapons (i.e. SMs) as they can to create their own 
niche. Figure 18 showing BGC hits detected by antiSMASH boxplot for each dataset, 
in relation to its assigned genus. 
 
Figure 18. BGC hits detected by antiSMASH boxplot for each dataset, in relation to its assigned genus. 
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The majority of the detected BGCs has antimicrobial activity such as NRPS, 
represents 27% of BGCs, which was reported to have antibacterial activity and one 
major example of this group is β-lactams and some has also an antitumor activity 
(Felnagle et al., 2008). Terpene, bacteriocin, T1PKS, T3PKS, thiopeptide, betalactone, 
lanthipeptide, LAP and lassopeptide are also examples of such classes with an 
antimicrobial activity. On the other hand there should be a dialog and some sort of 
coordination between the community members through quorum sensing, this could be 
explained by the presence of homoserine lactone cluster (hserlactone) which known to 
has a rule in quorum sensing (Churchill et al., 2011). Butyrolactone also was detected 
which considered a type of signaling molecules that manage group of genes involved in 
the bacterial specialized metabolism and morphological differentiation (Horinouchi et 
al., 2001). Table 13 has more example of the potential use of the secondary metabolites 
detected in our analysis. 
Table 13. Potential application of some detected secondary metabolites 
BGC class Potential application Reference 
NRPS 
The majority has antibacterial activity (e.g. β-lactams) and 
antitumor effect (e.g. bleomycin)  
Felnagle et al., 2008 
Saccharides Some have antibacterial activity Weitnauer et al., 2001 





Subgroup of T1PKS are involved in antibiotic synthesis (e.g. 
erythromycin) 
Yu et al., 2012 
Polyketides 
(T3PKS) 
Antibacterial and antitumor activity Lim et al., 2016 
Phosphonate Have antibacterial activity (e.g. fosfomycin)  
Metcalf & van der Donk, 
2009 
Ectoine Have a potential use in prevention of Alzheimer’s Jorge et al., 2016 
Ras-RiPP 
Can produce peptides involved the control of a quorum sensing 
(QS) system 
Ye et al., 2020 
Phenazine Has a role as cell signals that regulate patterns of gene expression Pierson & Pierson, 2010 
Bacteriocin 
Peptidic toxins inhibit the growth of similar or closely related 
bacterial strains 
Cotter et al., 2013 
Arylpolyene 
Antioxidants which protect the bacteria from reactive oxygen 
species. 
Carter, J.; et al., 2016 
Siderophore Responsible mainly for iron transportation across cell membranes 
Cornelis P & Andrews 
SC, 2010 
Hserlactone Quorum sensing Churchill et al., 2011 
NAGGN Contribute to bacterial cell survival  
Matthias Kurz et al., 
2010 
RiPP 
Has more than 20 sub-classes with many applications (i.e. 
Antibiotics, food preservative, animal feed additives and in cell 
biology anantin is used as an atrial natriuretic peptide receptor 
inhibitor) 
Arnison PG et al., 2013 
Wyss DF et al., 1993 
Betalactone 
β-lactones appear in different NP classes, such as PKs, 
nonribosomal peptides and terpenoids. It has inhibition activities 
for ligases, transferases, oxidoreductases and hydrolases. 
Robinson et al., 2018 
Lehmann et al., 2018 
Sactipeptide A member of bacteriocin class I which has antimicrobial activity. Arnison PG et al., 2013 
Lanthipeptide A member of bacteriocin class I which has antimicrobial activity. Arnison PG et al., 2013 
Lassopeptide A member of bacteriocin class I which has antimicrobial activity. Arnison PG et al., 2013 
45 
Resorcinol 
Has a structural roles in membrane formation and associated with 
wide biological activities such as antibacterial, cytotoxic, 
dermatotoxic, antioxidant and genotoxic  
H. Kikuchi et al., 2017 
Thiopeptide 
Has antimicrobial activity against several drug-resistance 
pathogens 
R Liao et al., 2009 
Nucleoside 
Could inhibit bacterial RNA polymerase and has antibacterial 
activity against drug-resistance bacteria  
SI Maffioli et al., 2017 
Butyrolactone 
Type of signaling molecule that manages group of genes 
involved in the bacterial specialized metabolism and 
morphological differentiation. 
Horinouchi et al., 2001 
Ladderane Potential biofuel  Javidpour, P et al., 2016 
LAP Has antibacterial activity  DY Travin et al., 2019 
hglE-KS 
Type of Polyketide synthases (PKS) which has many 
pharmaceutical activities such as antibacterial, antifungal & 
antitumor. 
Jenke-Kodama et al., 
2005 
 
Another example of such complex and diverse environment is COVID-19 patients’ 
samples. Five genera, Blautia, Lachnospiraceae, Bacteroides, Faecalibacterium and 
Streptococcus contribute by about 43% from a total number of 243 detected BGCs 
belong to 16 different classes. Nucleoside which could inhibit bacterial RNA 
polymerase and has antibacterial activity against drug-resistance bacteria, was unique 
to this environment (SI Maffioli et al., 2017). Gut microbiome of COVID-19 patients’ 
samples also were characterized by the presence of a wide array of bacteriocin, peptidic 
toxins which have the ability to inhibit the growth of similar or closely related bacterial 
strains (Cotter et al., 2013) in addition to the presence of sactipeptide, lanthipeptide and 
lassopeptide which considered members of bacteriocin class I which have antimicrobial 
activity (Arnison PG et al., 2013). Moreover, thiopeptide was also detected which has 
an antimicrobial activity against several drug-resistance pathogens (R Liao et al., 2009). 
Figure 19 is a heatmap for each dataset with each of the BGC hits from antiSMASH in 
relation to its assigned genus. 
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Figure 19. Heatmap for each dataset with each of the BGC hits from antiSMASH in relation to its 
assigned genus. 
Sewage samples comes in the third place in terms of the number of detected BGCs with 
a total of 102 BGCs belonging to 12 different classes. Here about 50% of the detected 
BGCs comes from 3 different genera, Streptococcus, Neisseria and Polaromonas. 
Different BGCs classes with antimicrobial activity were detected such as bacteriocin, 
terpene, NRPS-like, sactipeptide and T3PKS.  This environment was characterized also 
by the presence of many signaling and regulating classes such as hserlactone, 
butyrolactone, phenazine and RaS-RiPP. The last two classes were unique to this 
environments where phenazine, has a role as cell signals that regulate patterns of gene 
expression (Pierson & Pierson, 2010) while RaS-RiPP, a product of Streptococcus 
Agalactiae, can produce peptides involved in the control of a quorum sensing (QS) 
system (Ye et al., 2020). On the other hand, phenazine could be a good example to 
prove that some species might produce new metabolites under different environmental 
conditions, in this study we noticed that Escherichia coli from sewage water samples 
only produce phenazine in such environment and we didn’t recognize this elsewhere 
from any other projects. 
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Many other BGCs’ classes were detected in other samples such as saccharides which 
also have antibacterial activity especially the subset which has a cellular diffusible 
ability (Weitnauer et al., 2001). Type 1 Polyketides were reported to be involved in 
antibiotic synthesis such as erythromycin and oxytetracycline (Yu et al., 2012), while 
type 3 Polyketides were known about their antibacterial and antitumor activities (Lim 
et al., 2016). 
In this study, some environments such as Tonga trench doesn’t have a signature 
microbial composition. However, the genus Chewanella was characteristic to this 
environment by producing a unique product (i.e. Phosphonate) which had been reported 
to have antibacterial activity and one famous example is fosfomycin (Metcalf & van der 
Donk, 2009), at the time of sampling, this species might started to fight to create its own 
niche. This could be studied over a course of time to detect the environmental microbial 
composition change over time.  
Comparison of BGCs as detected by DeepBGC and antiSMASH  
 
By using both pipelines we noticed some major differences between them and 
could be summarized in the following points; antiSMASH was more power in detecting 
the exact BGC class, on the other hand, deepBGC detects a huge amount of BGCs 
compared to antiSMASH. A total 776 BGCs were detected by antiSMASH from the 
selected projects and only 45 samples from 65 processed samples gave hits, while 
deepBGC detected large number of BGCs, a total 79,771 BGCs were detected from the 
selected projects, moreover all the 65 samples gave hits. AntiSMASH detected 26 
different BGC classes and the seven major classes detected in this study which 
collectively represent about 80% of the total detected BGCs classes were NRPS (23%), 
bacteriocin (15%), NRPS-like (10%), terpene (10%), sactipeptide (9%), arylpolyene 
(7%) and siderophore (5%). On the other hand, deepBGC assigned BGCs classes to 
only around 20% of hits (15,714 hits) as follows; 39% of hits was Polyketide, 18% 
RiPP, 18% Saccharide, 10% others, 7% NRP, 4% Terpene, 2% Polyketide-Terpene, 1% 
NRP-Polyketide and 1% Saccharide-Terpene. Although deepBGC could annotate only 
six classes (i.e. Alkaloid, NRP, Polyketide, RiPP, Saccharide and Terpene), however it 
has a major advantage as it could assign product activity to each single detected BGC 
class with a very high coverage rate (Figure 20). In this study deepBGC assigned 
product activity to 96% of the hits and the results were 97% of hits have an antibacterial 
48 
activity, 1% inhibitor, 1% antibacterial-antifungal and less than 1% cytotoxic. Table 5 
had a detailed comparison between antiSMASH and deepBGC in terms of the detected 
BGC classes with their corresponding percentage and the name and percentage of the 
most abundant contributed genera. 
 
(chair) J., 2014). According to ECDC,  the European Center of Disease Prevention and 
Control, antimicrobial resistance infections cause every year around 23,000 and 25,000 
deaths in the US and Europe, respectively (CDC infographic, 2019).  Such figures 
mandate the need of novel natural products discovery with novel mechanisms of action. 
To reach this goal, we tried to contribute in the first part of our study through catalog 
the BGCs of different bacterial species from the selected metagenomes as this would 
help a lot in understanding the dynamics of SMs between related or different microbes 
and hopefully this would help. In the same context, the second major goal of this 
Figure 20. BGC hits detected by DeepBGC (product activity assigned) boxplot for each dataset, 
in relation to its assigned genus. 
AMR genes profile of samples in the dataset as detected by CARD’s RGI 
Around 700,000 deaths yearly due to infection by resistant microbes (O’Neill 
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research was to detect the antimicrobial resistance genes of the samples from the 
selected metagenomes, along with their mechanisms of actions and the drug classes 
which it confers resistance to. This also would greatly help to understand the different 
factors affecting the development of resistance and the possibility of spreading this 
resistance between closely related or even different bacterial strains through Horizontal 
Gene Transfer (HGT). Here we used Resistance Gene Identifier (RGI) algorithm from 
The Comprehensive Antibiotic Resistance Database (CARD) for AMR genes detection. 
From the sixty five processed samples from the different seven selected metagenomes, 
CARD’s RGI recognized a total number of around 1216 AMR gene families which 
confer resistance to about 2602 drug classes by 1163 resistance mechanisms. The largest 
percentages of results, more than 70%, were from the samples of both gut microbiome 
of COVID-19 patients and water sewage (Figures 8 – 10) and they also share many of 
aspects as follows; among the fifty five and thirty seven different AMR gene families 
of gut microbiome of COVID-19 patients and water sewage, respectively, the first 
major two AMR gene families were resistance-nodulation-cell division (RND) 
antibiotic efflux pump and  major facilitator superfamily (MFS) antibiotic efflux pump 
they represent the highest percentages; 45.75% and 45.65% of gut microbiome of 
COVID-19 patients and water sewage samples, respectively. Therefore, the major 
resistance mechanism in both samples was antibiotic efflux which represents 47.93% 
in gut microbiome of COVID-19 patients’ samples and 45.38% in water sewage 
samples. Although, gut microbiome of COVID-19 patients’ samples comes in the first 
place in the number of the detected drug classes, 1378 drugs of different 32 classes, and 
water sewage comes next with 1031 drugs from different 29 classes, they were also 
relatively similar in terms of kind of drug classes. The first three major drug classes 
detected in both samples were tetracycline antibiotic, fluoroquinolone antibiotic and 
penam which collectively represent around 35.92% and 36.95% of all detected drug 
classes from gut microbiome of COVID-19 patients and water sewage samples, 
respectively.   
The rest of samples from the other projects show also similar results with a very 
low abundance compared to gut microbiome of COVID-19 patients’ samples and water 
sewage samples. Antibiotic efflux pump AMR gene families both RND and MFS also 
represent the highest percentages; they represent 58.33% & 19.67% of all detected 
AMR gene families of Osaka and skin AD samples, respectively. However, there was 
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a slight difference in the order of resistances mechanisms between them, antibiotic 
efflux comes in the first place and represents 51.61% of the three detected mechanisms 
of Osaka samples while antibiotic inactivation comes first by 35% and antibiotic efflux 
was in the third place by 23.33% from the five different detected resistance mechanisms 
of skin AD patients samples. Moreover, the major drug class detected in both samples 
was aminoglycoside antibiotic by 14.85% and 12.99% from skin AD and Osaka 
samples, respectively. The results of the last samples from the rest three metagenomes, 
Nose, Tonga and Mangrove, represent the smallest fraction of all results. Their 
combined results were less than 1% compared to the rest of results. No perfect hits were 
detected and only few strict hits were reported as follows, 3 hits, 1 hit and 1 hit from 
Nose, Tonga and Mangrove projects, respectively. 
The effect of antibiotic use in AMR genes transfer between microbial communities  
We tried to find a connection between the detected BGCs in the first part of our 
study and AMR genes detected by CARD. Although, the ten samples of skin AD 
patients were the first among the rest metagenomes in terms of the number of detected 
BGCs, 272 BGCs from 19 different classes, it comes in the 4th place in terms of the 
normalized percentage of detected AMR genes after the samples of gut microbiome of 
COVID-19 patients, Sewage and Osaka metagenomes. Therefore, another reason other 
than the degree of microbial diversity should be responsible for putting the microbial 
communities under stress and bush them to share their resistance genes horizontally. 
This might be the reason behind the high abundance of the detected AMR genes, around 
70%, from gut microbiome of COVID-19 patients and water sewage samples. To 
eliminate the effect of sample size on results, this percentage was normalized to the total 
number of bases per each project. Results show a degree of similarity between both 
samples, this might be due to a common factor drives their respective bacterial 
communities toward sharing their AMR genes. Microbial communities of both gut 
microbiome of COVID-19 patients’ samples and water sewage sample exposed to 
abroad spectrum of antibiotics from different classes with different doses, such common 
factor would be of a great impact on the development of a huge number of highly 
resistant bacterial strains. In the next part, we will try to highlight some important results 
from both environments and trying to relate this to the recent researches. 
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AMR genes in gut microbiome of COVID-19 patients’ samples 
Regardless the fact that COVID-19 is a viral infection, many people around the 
world in low, middle and also high-income countries think that the use of antibiotics 
would help in the treatment and/or prevention of infection. In the same context and 
according to the European division of WHO, there were results of behavioural insight 
research from nine European countries prove that the antibiotic use increasing along 
with cases throughout the pandemic, around 79 – 96% of those taking antibiotics, were 
reported not infected with COVID-19 but they believe that the use of antibiotics is the 
proper preventive action. Moreover, results show that 75% of COVID-19 patients used 
antibiotics while only 15% of them develop bacterial co-infection and could need 
antibiotics (WHO, 2020). On the other hand, in Italy when the pandemic strikes, 
according to Dr Nino Berdzuli, Director of WHO/Europe’s Division of Country Health 
Programmes, they gave COVID-19 patients broad spectrum antibiotics such as 
cephalosporins and azithromycin, this was the routine treatment of community-acquired 
pneumonia cases. To date, azithromycin still used as the first choice antibiotic in such 
cases worldwide on the basis of its immunomodulatory action. Here we reported that 
about 15% AMR genes confer resistance to cephalosporin and macrolide antibiotic 
drugs classes, azithromycin belongs to macrolides, and this would show a direct relation 
between the use of antibiotics and the development of antimicrobial resistance. A recent 
recovery trial in the UK published on 14 December, 2020 shows that azithromycin with 
no benefit to patients hospitalized with COVID-19. In this trial a total 2582 patients 
taking azithromycin were compared to 5182 patients randomized to the usual care alone 
(Horby et al., 2020). The situation is even worse, a study published on March, 2020 
conducted in intensive care units from 88 countries on total 15165 COVID-19 patients, 
showed that 70% of them received antibiotics, at least one, for treatment or even 
prophylaxis purposes where only 54% of them had proven bacterial co-infection 
(Vincent JL et al., 2020). The wide use of biocidal agents as disinfectants in non-
clinical, would be another possible threat. It has been reported that even the low 
exposure to these agents leads to the selection of drug resistance microorganisms, 
particularly gram negative bacteria (Kampf G., 2018). Our results showed that gut 
microbiome of COVID-19 patients’ samples were the first among the selected 
metagenomes in terms of number of detected hits with total 544 hits. Moreover, it has 
the highest percentage of detected AMR gene families (48.26%) of different 55 families 
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which confer resistance to around 51.51% of drugs from different 37 classes by six 
different mechanisms. This might explain the reported fatal co-infection by 
exceptionally antibiotic resistance bacteria in gut microbiome of COVID-19 patients 
(Sharifipour E. et al, 2020). There should be a strict regulation from the health 
authorities around the world to avoid using antibiotics in cases where no sign of 
bacterial co-infection.  
AMR genes in water sewage 
Although, spread of antimicrobial resistance is a global clinical concern, this 
issue is not limited to the clinic. Antibiotics used by humans will at the end of the day 
end up in sewage, therefore waste water considered one of the biggest reservoir of 
antibiotics, AMR genes and bacterial from diverse sources and waste water treatment 
plants are usually one of the main sources of antibiotic-resistance bacteria and AMR 
genes spread into the environment (Rizzo, L. et al., 2013).  In our study, we reported 
466 hits from all samples of water sewage, 96 of hits were perfect and 370 were strict 
hits. This represents 23.37% of the detected AMR gene families from different 37 
families which confer resistance to 22.42% drugs from different 29 classes with 
different 6 resistance mechanisms. Waste water considered a hotspot of spreading 
resistance genes not only between closely related bacterial strains but also this could be 
happen between phylogenetically distant strains (Jiang, X. et al, 2017) this might be due 
to the selection pressure caused by pollutant compounds such as heavy metals, 
antimicrobial agents, biocides and drugs which could promote horizontal gene transfer 
(Aminov, R.I, 2011). Such selection pressure is a significant issue in the presence and 
spreading of AMR genes in sewage. Whenever there is a selection pressure for 
antimicrobial resistance bacteria, they overgrow the sensitive ones and they can share 
their resistance genes, which are usually included in mobile genetic elements (MGE), 
through one of the three major mechanism, transformation, transduction and 
conjugation (Karkman A et al., 2018). We reported here relatively big numbers of AMR 
gene families, 55 from gut microbiome of COVID-19 patients’ samples and 37 from 
water sewage, which confer resistance to many drug classes, 37 and 29, from gut 
microbiome of COVID-19 patients’ samples and water sewage samples, respectively. 
This could be explained by the fact that each MGE usually contains AMR genes for 
more than on antimicrobial compound. Therefore, AMR gene could be selected by a 
wide array of antibiotics which is the case in both environments. Moreover, the same 
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MGE might also contain AMR gene for heavy metal or disinfectant, this can also lead 
to a selection pressure for transferring antibiotic resistance between different bacterial 
species (Karkman A et al., 2017). Waste water contributed the most in transmission of 
AMR genes. Results from 63 studies, published between 2009 and 2019, were reviewed 
elsewhere, confirming the presence of wide range of AMR genes and antibiotic-
resistance bacteria in waste water around the world (Fouz N. et al., 2020). 
Antibiotic efflux resistance mechanism in gut microbiome of COVID-19 patients’ 
and water sewage samples 
 In bacterial drug efflux pumps have many functions other than their key role in 
drug resistance and there are escalating number of multiple drug efflux pumps reported 
from bacteria isolated from different ecological samples (Li X-Z and Nikaido H, Drugs, 
2009). In the current study, antibiotic efflux was the major detected resistance 
mechanism from both gut microbiome of COVID-19 patients’ and water sewage 
samples. It comes in the first place by 47.93% and 45.38% of the total detected 
resistance mechanisms from gut microbiome of COVID-19 patients and water sewage 
samples, respectively. It has been reported that efflux mediate drug resistance usually 
acts concurrently with other resistance mechanisms which reflects higher resistance to 
abroad spectrum of drugs. On the other hand, expression of drug pumps usually induced 
by many molecules such as antimicrobial agents, bile salts and biocides (Li X-Z and 
Nikaido H, Drugs, 2009), coupled with the fact that resistance genes usually present on 
plasmids and other mobile genetic elements, the possibilities of their induction and 
transfer between other bacteria in both gut microbiome of COVID-19 patients and waste 
water are very high. It has been reported that aminoglycosides and macrolides induce 
the expression of MexXY efflux pumps in P. aeruginosa (Jeannot K et al., 2005). 
Fluoroquinolones were also responsible of induction the expression of both AcrAB and 








Chapter 5: Conclusions and Future Perspectives 
Conclusions 
 This study has two main objectives. Firstly, the assembled contigs were 
investigated by two major distinct computational methods, namely antiSMASH and 
deepBGC methods. A comparative study was performed to determine BGCs present in 
each of the included samples, as well as comparing their taxonomic differences. 
Secondly, the assembled contigs were also analyzed to determine AMR genes present 
in each samples by using RGI algorithm which is a part of CARD. A total number of 
sixty five samples pertaining to seven selected metagenomic / metatranscriptomic 
projects were assembled, a total 1,139,543,039 reads were filtered to 1,100,630,009 
filtered reads and the obtained reads and assembled contigs (4,325,515 contigs) were 
subjected to taxonomic assignment. All assemblies were then investigated by two 
different computational tools in addition to CARD, the first tool was antiSMASH, the 
second tool was deepBGC and finally we used CARD to determine AMR genes in each 
ecosystem.  
 To determine BGC content in each environment, our first goal, both 
computational tools, antiSMASH and deepBGC, were run in parallel for BGC mining. 
Although both tools were complementary to each other, however, there were major 
differences between them, generally in terms of total number of the detected BGCs and 
the number of annotated BGC classes. AntiSMASH detected only 776 BGCs which 
represents less than 1% of the total number of detected BGCs by deepBGC (79,771 
BGCs). However, antiSMASH showed a higher accuracy in detecting the exact classes 
of BGCs and a higher annotation level. In this study antiSMASH annotated 26 different 
classes of BGCs compared to only 6 fixed classes annotated by deepBGC (i.e. Alkaloid, 
NRP, Polyketide, RiPP, Saccharide and Terpene) in addition to one extra unknown class 
named “other”. A major advantage of deepBGC was its ability to assign product activity 
to more than 95% of hits regardless the fact that only 20% of hits were got BGC class 
annotation by deepBGC. The majority of product activities assigned by deepBGC were 
97% antibacterial, 1% inhibitor, 1% antibacterial-antifungal and less than 1% cytotoxic. 
For more detailed comparison between antiSMASH and deepBGC in terms of the 
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detected BGC classes with their corresponding percentage and the name and percentage 
of the most abundant contributed genera, see (Table 5). 
 The taxonomical assignment were of great impact to understand the dynamics 
of SM production and the differences of BGCs classes detected from the different 
environments. We clustered all samples based on their relative abundance of taxa and 
their microbial composition by both PCA and t-SNE tools (Figures 5 & 6). Some 
samples from the same projects had a characteristic relative microbial abundance so 
they appeared nicely separated from the rest of samples such as the samples from both 
Osaka bay project which dominated mainly by Pseudomonas and water sewage project 
which had a very high relative abundance of and Streptococcus. Although, these two 
environments dominated mainly be one genus and it was expected to have a slightly 
low range of BGCs and if there a unique class of BGCs will be produced by other 
predominated genera to protect their niche, however, Pseudomonas from Osaka project 
produced a class of BGCs called N-γ-acetylglutaminyl glutamine 1-amide (NAGGN), 
has a role in bacterial cell survival (Matthias Kurz et al., 2010) and it was not detected 
elsewhere from any of the selected samples from all other projects, Streptococcus also 
from water sewage project produced Ras-RiPP, has a role in quorum sensing, which 
also was not detected in any other samples. Such examples are good evidence that, also 
microorganisms have characteristic behavior, however, it might behave in a different 
ways under different environmental conditions. This needs further investigations of 
such environments over a course of time to see how their behavior changes over time, 
could be a clear limitation of this study.  
On the other hand, we also expect to detect unique classes from some species 
which present in a very low abundance in some environments, here we reported two 
cases. In Tonga trench project antiSMASH detected a BGC class called phosphonate 
which was belonging to a genus called Shewanella which existed in a very low relative 
abundance compared to Cutibacterium. The second example was from the water sewage 
project, BGC class called phenazine was detected by antiSMASH and it was produced 
by E. coli which exhibits a low relative abundance compared to Streptococcus. 
We also noticed that the samples which had a large extent of variability (i.e. sex, 
age and illness state) due to the nature of their environments, such as microbiome 
samples of patients in two projects (COVID-19 & Atopic Dermatitis), gave the most 
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variable number of BGC classes detected by antiSMASH, where 19 different classes 
detected in skin microbiome of AD patients and 16 different classes detected in gut 
microbiome of COVID-19 patients’ samples while the third place in terms of total 
number of detected classes went to the water sewage project with 12 different classes 
detected and this could be also due to the same reason. AntiSMASH did not detect more 
than 10 different classes in the rest of projects.  
The second goal of this study was to determine the AMR genes in the selected 
metagenomes using CARD’s RGI algorithm. Due to the selection pressure on the 
microbial communities by the wide use of antibiotics, gut microbiome of COVID-19 
patients’ and water sewage samples had more than 70% of the detected AMR gene 
families as detected by RGI. Gut microbiome of COVID-19 patients’ samples came in 
the first place among the seven selected metagenomes by almost 50% of the total 
detected AMR genes, while samples of water sewage came in the second place by 
almost 25%. This might be a logical result of the misuse of antibiotics all over the world 
as the majority of people believe this could help in the prevention or treatment of the 
infection, as reported in many studies. In addition to the misuse of antibiotics, the wide 
use of disinfectants for environmental and personal hygiene was also a potential reason 
of spreading of antimicrobial resistance genes between different bacterial species. 
Under specific harsh conditions bacterial species behave in adaptive way to survive. 
One major mechanism, by which the resistant bacterial species would help the sensitive 
ones to survive is through sharing their resistance gene horizontally by well-known 
mechanism called horizontal gene transfer (HGT). Mobile genetic elements, transferred 
during HGT, such as plasmids often contain resistance genes for more than one 
antibiotic, moreover, in some cases the same element might contain resistance gene for 
a specific metal or disinfectant. Consequently, such resistance genes might be selected 
by the use of wide range of antibiotics, disinfectant and heavy metals. This applied to 
both environments (i.e. gut microbiome of COVID-19 patients and water sewage) 
because antibiotics and the other pharmaceutical drugs consumed by humans will 
eventually end up in sewage.   
Recent studies conducted on COVID-19 patients globally show the improper 
use of antibiotics along with many cases of fatal co-infection with highly resistant 
bacterial strains. In our study, gut microbiome of COVID-19 patients’ samples harbor 
bacterial species resistant to 37 different classes of antibiotics. About 15% of the 
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detected AMR genes were resistant to the two major antibiotic classes used in COVID-
19 infection, cephalosporins and macrolides. Despite the fact that the majority of cases, 
even if they are diagnosed as positive COVID-19, don’t need antibiotics as long as there 
is no sign of bacterial infection, 75% of patients take antibiotics. On the other hand, a 
recovery study conducted in the UK revealed that the use of azithromycin with COVID-
19 patients was with no effect compared to patients with same conditions randomized 
on the routine treatment without azithromycin.  
Overall, diverse environments harbor different microbial composition with 
dissimilar relative abundance of taxa and this leads to the presence of a wide variety of 
secondary metabolites in each environments in addition to the presence of a wide range 
of AMR genes in environments under specific selection pressure such as gut 
microbiome of COVID-19 patients’ and water sewage samples. Environments with 
high microbial diversity such as host microbiome (i.e. skin AD & gut COVID-19) 
harbor large percentage of BGCs, maybe due to the arms race between co-existing 
microorganisms. Both antiSMASH and deepBGC complemented each other to get a 
clearer picture about the nature of different environments in terms of the relative 
microbial abundance and their corresponding BGCs content. In addition to the degree 
of microbial diversity, environments under specific selection pressure by antibiotics, 
disinfectants and heavy metals, had the biggest percentages of AMR genes. COVID-19 
and water sewage harbor more than 70% of AMR genes detected by CARD’s RGI.  
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Future Perspectives  
There is no question that there is an escalating interest to investigate biosynthetic 
pathways to discover new natural products. Environments with rich microbial diversity 
such as host microbiome and marine ecosystems should be thoroughly mined for 
biosynthetic gene clusters and antimicrobial resistant genes using different 
computational tools in order to find explanation on how novel secondary metabolites 
are assembled and which microorganisms carry AMR genes and to what extent they are 
mobile. The information in this study will be of great value to other researchers who 
interested in either isolation of natural products or studying the antimicrobial resistance 
mechanisms. In addition to their therapeutic use, understanding the dynamics of 
secondary metabolites is crucial for studying different microbial populations and their 
effects on substance turnover. 
On the other hand, a time dimension could be a major limitation to this study, 
sampling over a course of time is critical to clearly understand the dynamics in each 
ecosystem. Few cases of interest were reported, we detect many SMs with antibacterial 
activity belonging to some genera, present in a relatively low abundance in highly 
diverse ecosystems, such as Pseudomonas from Osaka and Streptococcus from sewage 
water, they might be under stress and were trying to fight to create their own niche by 
producing their own weapons (i.e. SMs) at the time of sampling but we do not know 
how the situation could be changed over time. Moreover, the use of antibiotics and other 
factors such as disinfectants shift microbial populations toward sharing their resistance 
genes. Therefore, monitoring microbial environments over a course of time is very 
crucial to understand the microbial behavior under different conditions such as high 
competition and other stress environmental conditions such as antibiotics, disinfectants 
and heavy metals.  
Many evidences suggested that, the misuse of antibiotics has a direct 
contribution to the global widespread of antibiotic resistance. In this study, samples 
from gut microbiome of COVID-19 patients from Hong Kong showed very interesting 
results, it harbors the largest percentage of AMR genes, more than 50% of the detected 
AMR genes in all datasets. Many factors might be contributed to such results, it would 
be very important to compare our results with COVID-19 patients’ results from 
different places around the world, this would clearly unleash the role of the different 
59 
environmental factors contributed to the escalating burden of antibiotic resistance 
among COVID-19 patients.   
In the near future, we should see a new era of development of bioinformatics 
tools and software based on different machine learning approaches to eliminate any 
current limitations and also trying to put a clear workflow optimizing the mechanism of 
BGC and AMR gene detection and expression of their corresponding secondary 
metabolites and AMR genes, respectively. 
A final word to all people around the world, please keep antibiotics for patients 
with clear and documented signs of bacterial infection, the misuse of antibiotic will 
accelerate the arrival of the post-antibiotic era. Dr. Nino the director of WHO, European 
division said, “Everyone has a role to play as an antibiotic guardian, whether they are a 
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